Where can i buy kamagra oral jelly

Latest Alzheimer's where can i buy kamagra oral jelly News WEDNESDAY, Nov jelly viagra kamagra. 17, 2021 (HealthDay News) The first human clinical trial of a nasal treatment to slow the progression of Alzheimer's disease is set to begin after nearly 20 years of research. This is where can i buy kamagra oral jelly a "remarkable milestone," according to Dr.

Howard Weiner, co-director of the Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital in Boston. "Over the last two decades, we've amassed preclinical evidence suggesting the potential of this nasal treatment for AD [Alzheimer's disease]," Weiner said in a hospital news release. "If clinical trials in humans show that the treatment is safe and effective, this where can i buy kamagra oral jelly could represent a nontoxic treatment for people with Alzheimer's, and it could also be given early to help prevent Alzheimer's in people at risk." The treatment features an experimental agent called Protollin that stimulates the immune system.

It's designed to prompt white blood cells in the lymph nodes on the sides and back of the neck to migrate to the brain and clear beta amyloid plaques, a hallmark of Alzheimer's disease. According to Dr. Tanuja Chitnis, where can i buy kamagra oral jelly principal investigator in the trial, "For 20 years, there has been growing evidence that the immune system plays a key role in eliminating beta amyloid.

This treatment harnesses a novel arm of the immune system to treat AD." Chitnis is a professor of neurology at the hospital. "Research in this area has paved the way for us to pursue a whole new avenue for potentially treating not only AD, but also other neurodegenerative diseases," she added. The phase 1 trial will include where can i buy kamagra oral jelly 16 patients between 60 and 85 years of age who have early, symptomatic Alzheimer's disease but are otherwise in good general health.

They will receive two doses of the nasal treatment one week apart. Along with assessing the treatment's safety and how well patients tolerate it, the researchers will examine how it affects immune response, including its impact on white blood cells. The trial is funded by I-Mab Biopharma and Jiangsu Nhwa Pharmaceutical, developers and makers of where can i buy kamagra oral jelly Protollin.

More information The Alzheimer's Association has more on Alzheimer's disease. SOURCE. Brigham and where can i buy kamagra oral jelly Women's Hospital, news release, Nov.

16, 2021 Robert Preidt Copyright © 2021 HealthDay. All rights reserved. SLIDESHOW The Stages of where can i buy kamagra oral jelly Dementia.

Alzheimer's Disease and Aging Brains See SlideshowLatest Healthy Kids News WEDNESDAY, Nov. 17, 2021 (American Heart Association News) Family-based programs to encourage healthier eating and physical activity have long been regarded as an effective way to put children diagnosed as overweight or with obesity on a path to a better future. But new research suggests an added where can i buy kamagra oral jelly dividend.

Parents of those children can benefit as well. "It is known that parental where can i buy kamagra oral jelly involvement favorably affects children's weight management," said the study's lead researcher Nirupa Matthan, a scientist at the Human Nutrition Research Center on Aging at Tufts University in Boston. "We wanted to see if there is a spillover effect on the diet quality and cardiometabolic health outcomes of the parents, and for the first time we showed that the answer is yes." Matthan presented her findings this past weekend at the American Heart Association's Scientific Sessions virtual conference.

The work is considered preliminary until published in a peer-reviewed journal. The analysis drew on data from a clinical trial of several hundred children in the Bronx who participated in a one-year weight management program with a combination of doctor's care, nutrition education, where can i buy kamagra oral jelly group support sessions and physical activity strategies involving both the child and their parent. Matthan and colleagues have previously reported that children participating in the comprehensive family-based program adopted healthier eating patterns and modestly improved their body weight and some other health measures.

But Matthan didn't want to stop there. "I was interested in finding out whether the parents just support the children or are they actually where can i buy kamagra oral jelly changing their behavior and serving as role models," she said. "If they are, you should see an improvement in the parents' weight as well as the parents' health outcomes." Obesity, which can lead to Type 2 diabetes, heart disease and some cancers, is a growing problem for Americans at every age.

According to the Centers for Disease Control and Prevention, 19.3% of children and adolescents ages 2 to 19 – about 14.4 million – were obese in 2018. That same year, 42.4% of adults were, up from 30.5% where can i buy kamagra oral jelly two decades earlier. The analysis didn't just include weight and body mass index before and after the year-long program.

The researchers also checked blood pressure and took blood samples from children and the parents, yielding biomarkers for diet quality as well as blood sugar and cholesterol for a more detailed health assessment. In her follow-up where can i buy kamagra oral jelly study, Matthan divided the children into three groups based on weight change. Those who made significant improvement, those who had little or no change, and those whose results were worse.

In all three groups, she said, the parents' results mirrored their children's, particularly in the group that showed the most improvement. "Obesity runs in where can i buy kamagra oral jelly families," Matthan said. "But we tend to treat children and adults separately.

If you do this family-based approach, you can target both, and that's where you'll have the most public health impact." Myles Faith, a professor of counseling, school and educational psychology at the University at Buffalo - The State University of New York, called the study "novel and exciting," particularly because it examined risk factors beyond weight that can lead to heart disease. "It's one of the first to look at parent-child relationships specifically focusing where can i buy kamagra oral jelly on cardiometabolic risk factors and studying it as a family relationship in response to treatment," said Faith, who was not involved in the research. "These data strongly support the need for family-based interventions." QUESTION Some children are overweight because they have big bones.

See Answer Faith helped write a 2020 AHA scientific statement that gives parents and adult caregivers strategies to create a healthy food environment for young children that doesn't focus on weight. It encouraged allowing kids to pick where can i buy kamagra oral jelly what foods they want to eat from a selection of healthy foods. Eating new, healthy foods with children and showing you enjoy the food.

Having meals at where can i buy kamagra oral jelly consistent times. And not pressuring kids to eat more than they want. "We think of the parents as the agent of change for the child," Faith said.

The new research where can i buy kamagra oral jelly "shows it can go the other way, too. Children can inspire their parents as well to up their game and make the changes themselves. It's a win for the whole family." American Heart Association News covers heart and brain health.

Not all views expressed in this where can i buy kamagra oral jelly story reflect the official position of the American Heart Association. Copyright is owned or held by the American Heart Association, Inc., and all rights are reserved. If you have questions or comments about this story, please email [email protected].

By Michael Precker American Heart Association News Copyright where can i buy kamagra oral jelly © 2021 HealthDay. All rights reserved. From Parenting &.

Children's Health Resources Featured Centers Health Solutions From Our SponsorsLatest Neurology News By Dennis where can i buy kamagra oral jelly Thompson HealthDay ReporterWEDNESDAY, Nov. 17, 2021 (HealthDay News) Claire Wiedmaier experiences epileptic seizures so bad that she's broken teeth while in their grip. "I have some fake teeth.

I broke my two bottom front teeth," said Wiedmaier, 23, of Ankeny, Iowa, who these days can expect to where can i buy kamagra oral jelly have at least four seizures a month. Knowing when to expect a seizure would be a big help to her. "It would be nice to know, because then I could get somewhere safe," Wiedmaier said.

"I could get out of public or get on where can i buy kamagra oral jelly the bed, get out of the shower. Having a seizure in the shower is not very good." Investigators now think they're on the path to accurately predicting epileptic seizures by using a wristband device that tracks different body signals. The researchers identified patterns among patients that could allow about a half-hour of warning before a seizure occurs, according to findings published online recently in the journal Scientific Reports.

"On average, we were predicting about two-thirds of patients' seizures accurately," said senior researcher Benjamin Brinkmann, an epilepsy scientist with the Mayo Clinic in Rochester, Minn where can i buy kamagra oral jelly. Previous studies of epilepsy have determined that seizure forecasting is possible, based on data gained from brain implants placed in people's heads to help control seizures, said Jacqueline French, chief medical officer of the Epilepsy Foundation in Bowie, Md. "Some very smart researchers started to look at the patterns of epileptic activity in where can i buy kamagra oral jelly people's brains and say, you know, this is not random.

This is not a random pattern," said French, a professor of neurology with NYU Langone School of Medicine in New York City. "It seems like people would have a tendency to have a rise of epileptic activity which would happen at regular intervals." However, until now there's been no non-invasive way to gather the sort of data that might allow such a prediction to occur. About one-third of people with epilepsy where can i buy kamagra oral jelly have seizures that can't be controlled, French said.

"We want to do something for them, too. We don't want to forget about them," she said. Wiedmaier was one of where can i buy kamagra oral jelly six people with drug-resistant epilepsy who wore the wristband gadget, which is a medical-grade device already on the market to help track different physical data from patients.

Participants were asked to wear the device for six months to a year, and upload data every day to cloud storage. Brinkmann said the wristband collected much of the same data as would a lie detector — blood flow, skin response, heart rate, temperature, movement. "We used that along with their seizure record to train a machine learning model, an where can i buy kamagra oral jelly [artificial intelligence] algorithm," Brinkmann said.

The algorithm took a look at each individual patient and tried to figure out the specific "tells" that would predict when he or she would be at highest risk for a seizure. It was different for each patient, Brinkmann said. For some, where can i buy kamagra oral jelly their heart rate would signal an oncoming rise in epileptic activity.

In others, their skin response. The researchers then continued to track the patients to see if their algorithm would make accurate predictions. All six patients had deep brain stimulation implants to treat their where can i buy kamagra oral jelly epilepsy, and the investigators used those devices to confirm seizures.

"They did let me know when I had a seizure, if the watch was kind of right. They would let me know if that happened," Wiedmaier said. "They said my case was the most accurate out of everyone they had try it." French cautioned that while such devices may one day where can i buy kamagra oral jelly be able to predict seizures, it's more akin to storm forecasting than a tornado alert.

"You know there is a storm and during that storm there is a very high likelihood that lightning will strike, but to try and predict the exact moment when it will strike is much, much harder than predicting the storm," French explained. But just knowing that the epileptic "storm" is coming could be a huge benefit to patients with poorly controlled epilepsy, she added. Rescue medications can ward off seizures, and people can take other steps to improve their chances of avoiding one — such as getting good sleep and making sure they're taking their where can i buy kamagra oral jelly long-term epilepsy drugs as prescribed, French said.

SLIDESHOW What Is Epilepsy?. Symptoms, Causes, and Treatments See Slideshow People where can i buy kamagra oral jelly also would benefit from knowing that there's no seizure risk in their near future, she added. "We may get so good at that that we can tell people, 'Look, you have a day today that you will not have a seizure.' Then they can do all the things they normally wouldn't do because they absolutely cannot tell when the next seizure will occur," French said.

"It will give people more control." While the technology already is available, Brinkmann said an algorithm that will reliably predict epileptic seizures is still years away. "It'll be a where can i buy kamagra oral jelly fair bit of time. We have to confirm this is accurate and reliable," he said.

"This is a promising early result. We hope to push this forward to something that's useful where can i buy kamagra oral jelly for patients. We're not there yet." Wiedmaier said she'll be first in line if it does become available.

"I definitely think that would be awesome, and I definitely would purchase one. It would be good for a lot of where can i buy kamagra oral jelly people with epilepsy," she said. More information The Epilepsy Foundation has more about epilepsy.

SOURCES. Benjamin Brinkmann, PhD, epilepsy scientist, where can i buy kamagra oral jelly Mayo Clinic, Rochester, Minn.. Jacqueline French, MD, chief medical officer, Epilepsy Foundation, Bowie, Md., and professor, neurology, NYU Langone School of Medicine, New York City.

Claire Wiedmaier, 23, Ankeny, Iowa. Scientific Reports, Nov where can i buy kamagra oral jelly. 9, 2021, online Copyright © 2021 HealthDay.

All rights reserved. From where can i buy kamagra oral jelly Brain &. Nervous Resources Featured Centers Health Solutions From Our SponsorsLatest Chronic Pain News WEDNESDAY, Nov.

17, 2021 (HealthDay News) A 3-D virtual reality system to treat back pain was approved by the U.S. Food and Drug where can i buy kamagra oral jelly Administration on Tuesday. The EaseVRx system is a prescription device for at-home use that combines cognitive behavioral therapy and other behavioral methods to treat patients 18 and older with chronic lower back pain.

"Millions of adults in where can i buy kamagra oral jelly the United States are living with chronic lower back pain that can affect multiple aspects of their daily life," said Dr. Christopher Loftus, acting director of the Office of Neurological and Physical Medicine Devices in the FDA's Center for Devices and Radiological Health. "Pain reduction is a crucial component of living with chronic lower back pain.

Today's authorization offers a treatment option for pain reduction that does not include where can i buy kamagra oral jelly opioid pain medications when used alongside other treatment methods for chronic lower back pain," Loftus said in an agency news release. Pain experts welcomed the approval. "It is exciting to see virtual reality [VR] devices being utilized to treat chronic pain as these devices and software become more affordable and accessible to patients," said Dr.

Yili Huang, director of pain management at Northwell Health's Phelps Hospital in where can i buy kamagra oral jelly Sleepy Hollow, N.Y. "It is believed that VR helps treat pain by distraction, focus shifting away from the painful stimulus and helping the patient build the necessary skills to manage their own pain," he said. "The EaseVRx treatment program seems to have successfully combined all three of these methods to help patients treat pain.

"The study results are promising because not only did the treatment demonstrate a decrease in pain, but it also demonstrated a decrease in where can i buy kamagra oral jelly pain interference with activity, mood, sleep and stress, indicators that this treatment can help patients not only improve pain, but more importantly, quality of life," Huang added. The EaseVRx system includes a virtual reality headset and controller, and a "breathing amplifier" that directs a patient's breath toward the headset microphone for use in deep breathing exercises. The system uses a number of cognitive behavioral therapy (CBT) methods to achieve pain relief, including deep relaxation, self-compassion, acceptance, visualization, attention-shifting and healthy movement, the FDA said in the release.

A treatment program includes 56 VR sessions that are 2 to 16 minutes long as part of a daily eight-week treatment program. The FDA approval is based on a clinical trial that included 179 patients with chronic lower back pain assigned to one of two eight-week VR programs. The EaseVRx 3-D program or a control 2-D program that did not feature CBT methods.

At the end of treatment, 66% of EaseVRx participants reported a greater than 30% reduction in pain, compared to 41% of those in the control group. A greater than 50% pain reduction was reported by 46% of the EaseVRx users, compared with 26% of those in the control group, according to the FDA. One, two and three months after treatment, all EaseVRx users still reported a 30% reduction in pain, which was higher than in the control group.

Nearly 21% of EaseVRx users reported discomfort with the headset and about 10% reported motion sickness and nausea, but there were no serious side effects associated with the system, which is made by AppliedVR. Huang pointed out that the study had some limitations. "Although any safe, opioid-free pain treatment is a welcome addition during the opioid epidemic, it is important and somewhat disappointing to note that EaseVRx had no effect on opioid use in this study," he said.

"It is also important to note that the study subjects were mostly college-educated Caucasian women, and any patients with medical conditions that can cause nausea and dizziness were excluded," Huang said. "This means that we cannot assume that all patients from diverse backgrounds will have the same benefits." SLIDESHOW Back Pain. 16 Back Pain Truths and Myths See Slideshow.

How to buy kamagra in usa

Kamagra
Vigora
Cialis daily
Levitra soft
Viagra with dapoxetine
Cialis sublingual
Can cause heart attack
No
No
No
20mg
Yes
No
Australia pharmacy price
50mg 60 tablet $104.95
100mg 60 tablet $167.95
5mg 360 tablet $395.95
20mg 20 soft tab $69.95
$
20mg 270 tablet $625.95
How long does stay in your system
Yes
Online
No
Online
No
Online
Best price for generic
Yes
Online
Yes
No
Online
Online

GPT-3 demonstrates how to buy kamagra in usa a broader trend in artificial intelligence. Deep learning, which has in recent years become the dominant technique for creating new AIs, uses enormous amounts of data and computing power to fuel complex, accurate models. These resources are more accessible for researchers at large companies and elite universities. As a result, a study from Western University suggests, there has been a "de-democratization" how to buy kamagra in usa in AI.

The number of researchers able to contribute to cutting-edge developments is shrinking. This narrows the pool of people who are able to define the research directions for this pivotal technology, which has social implications. It may even be contributing to how to buy kamagra in usa some of the ethical challenges facing AI development, including privacy invasion, bias and the environmental impact of large models. To combat these problems, researchers are trying to figure out how to do more with less.

One such recent advance is called “less than one”–shot learning (LO-shot learning), developed by Ilia Sucholutsky and Matthias Schonlau from the University of Waterloo.[Office1] [RK2] The principle behind LO-shot learning is that it should be possible for an AI to learn about objects in the world without being fed an example of each one. This has been a how to buy kamagra in usa major hurdle for contemporary AI systems, which often require thousands of examples to learn to distinguish objects. Humans, on the other hand, are often able to abstract away from existing examples in order to recognize new never-before-seen items. For example, when shown different shapes, a child is able to easily distinguish between the examples and to recognize the relationships between what they were shown and new shapes.

The team how to buy kamagra in usa first introduced this sort of learning through a process called soft distillation. An image database maintained by the National Institute for Standards and Technology, called MNIST, which contains 60,000 examples of written digits from 0 to 9, was distilled down to five images that blended features of the various numbers. After being shown only those five examples, the University of Waterloo system was able to accurately classify 92 percent of the remaining images in the database. In their latest paper, the team has extended this principle to show that, theoretically, LO-shot techniques allow AIs to potentially learn to distinguish thousands of objects how to buy kamagra in usa given a small data set of even two examples.

This is a great improvement on traditional deep-learning systems, in which the demand for data grows exponentially with the need to distinguish more objects. Currently, LO-shot’s small data sets need to be carefully engineered to distill the features of the various classes of objects. But Sucholutsky is seeking to further develop this work by looking at the relationships between objects already how to buy kamagra in usa captured in existing small data sets. Allowing AIs to learn with considerably less data is important for several reasons.

First, it better encapsulates the actual process of learning by forcing the system to generalize to classes it has not seen. By building in abstractions that capture the relationships between objects, this technique how to buy kamagra in usa also reduces the potential for bias. Currently, deep-learning systems fall prey to bias arising from irrelevant features in the data they use to train. A well-known example of this problem is that AI classifies dogs as wolves when shown images of dogs in a snowy environment—because most images of wolves feature them near snow.

Being able how to buy kamagra in usa to zero in on relevant aspects of the image would help prevent these mistakes. Reducing data needs thus makes these systems less liable to this sort of bias. Next, the less extensive the data one needs to use, the less incentive exists to surveil people to build better algorithms. For example, soft how to buy kamagra in usa distillation techniques have already impacted medical AI research, which trains its models using sensitive health information.

In one recent paper, researchers used soft distillation in diagnostic x-ray imagery based on a small, privacy-preserving data set. Finally, allowing AIs to learn with less plentiful data helps to democratize the field of artificial intelligence. With smaller AIs, academia can remain relevant and how to buy kamagra in usa avoid the risk of professors being poached by industry. Not only does LO-shot learning make the barriers to entry lower by reducing training costs and lowering data requirements, but it also provides more flexibility for users to create novel data sets and experiment with new approaches.

By reducing the time spent on data and architecture engineering, researchers looking to leverage AI can spend more time focusing on the practical problems they are aiming to solve.1971 Antievolution Evolves “In recent months the teaching of evolution has come under attack in a number of states. The revival how to buy kamagra in usa of fundamentalism in biology takes a somewhat new form. The emphasis is on opposition to current theories of the origin of life and the diversity of species not by theologians but by scientists. The movement is led by the Creation Research Society, whose members have appeared before state boards of education and textbook committees in California, Texas, Arkansas and Tennessee.

The society's credo says that it is ‘committed to full belief in the Biblical record of creation and how to buy kamagra in usa early history’ and that its goal is ‘the realignment of science based on theistic creation concepts.’” Joy of Pulsars “The origin of the energy input to the Crab Nebula had been a puzzle that had long defied attempts at solution. Among the various possibilities considered, John Archibald Wheeler at Princeton in 1966 and Franco Pacini at Cornell in 1967 had independently put forward the apparently far-fetched idea that a rotating neutron star might be the energy source. Now, after the fact, it is possible to use the observations of the Crab Nebula and its pulsar (NP0531) to invert the problem and show that if the pulsar is a rotating star, it must have the mass and radius of a neutron star. In other words, even without the theory developed over the past 40 years, it is possible to assert that stars of approximately one solar mass and how to buy kamagra in usa radii on the order of 10 kilometers must exist since the pulsar in the Crab Nebula is such a star.

€”Jeremiah P. Ostriker” 1921 Truck Transport “This is the era of the motor truck. Yesterday it was how to buy kamagra in usa the railroad. Before that it was the stage coach.

And still further back it was the canal. The motor truck, and by that how to buy kamagra in usa we mean modern highway transportation, has come into its own. It has defined its field of service and established itself therein. In the field of short-haul transportation, the motor truck is the last word in efficiency.

The use of the motor truck, both in the handling of passengers and freight, is entirely an economic proposition for the benefit, according to the leading motor truck authorities, of how to buy kamagra in usa the country at large. If that is so, there is no justification for limiting by legislation the use of the highway by that vehicle.” Connecting Coast to Coast “The Longest Land Line in the United States was recently opened to the public by the Western Union Telegraph Company, giving direct communication between New York and Seattle. Four messages simultaneously each way can be sent over the single copper strand.” 1871 Thomas Henry Huxley “Although Dr. Huxley is profoundly learned in natural how to buy kamagra in usa history, he has also found time for general literary culture, and is fond of poetry, fiction, and fine writing.

It is this wide culture that gives him such power in his controversial writings. He seems to like nothing better than a regular set-to with some members of the old-school scientists, and he has sometimes been accused of exhibiting a pugnacious and acrimonious spirit. On one occasion Samuel Wilberforce, Bishop of Oxford, blandly asked him in the presence of a large audience. €˜Is the learned how to buy kamagra in usa gentleman really willing to have it go forth to the world that he believes himself to be descended from a monkey?.

€™ Professor Huxley rose and replied in his quiet manner, ‘Whether I should be descended from a respectable monkey, or from a bishop of the English church, who can put his brains to no better use than to ridicule science and misrepresent its cultivators, I would certainly choose the monkey!. €™â€ Camels in Nevada “On a ranch on the Carson river is to be seen a herd of twenty-six camels, all but two of which were born and raised in this State. The camel may now be said how to buy kamagra in usa to be acclimated to Nevada. The ranch upon which they are kept is sandy and sterile in the extreme, yet the animals feast and grow fat on such prickly shrubs and bitter weeds as no other animal would touch.

When left to themselves, their great delight, after filling themselves with the coarse herbage of the desert, is to lie and roll in the hot sand. They are used in packing salt to the mills on the river, from the marshes lying in the deserts, how to buy kamagra in usa some sixty miles to the eastward. Some of the animals easily pack 1,100 pounds.”Ever since the deadly parasite responsible for malaria was discovered in the late 19th century, science and global health experts have been waging a vigorous Sisyphean battle against the disease it causes. Humans have brought an arsenal of tools—nets, rapid tests, medication—to bear against the mosquito-borne parasite, which cannily mutates to become resistant to drug treatments.

We’re holding how to buy kamagra in usa our own. Global malaria deaths declined to 409,000 in 2019, compared to 585,000 in 2010, and a number of countries have eliminated it altogether or are on the verge of doing so. However, more than 90 percent of the deaths occur in Africa, and there is a threat that could set progress back again. Researchers in Rwanda identified a strain how to buy kamagra in usa of the malaria parasite P.

Falciparum with mutations on a gene known as K13 that enable resistance to artemisinin, the foundation of artemisinin-based combination therapies (ACTs), the most commonly used malaria treatments. While ACTs still work, a weakened treatment regimen could lead to more deaths on the continent, an increased spread of resistance itself, and loss of confidence in malaria treatment. We must act now to increase surveillance and monitoring for signs of new K13 mutations, even as we battle how to buy kamagra in usa the erectile dysfunction treatment kamagra. In addition to basic tactics like increasing people’s access to insecticide-treated mosquito nets, here’s what can help make a difference.

Ensure that providers and patients use drugs effectively. When providers don’t prescribe treatments correctly or their patients don’t take the complete course as prescribed, it contributes to the emergence of drug-resistant malaria how to buy kamagra in usa parasites. Governments and global health programs need to reinforce effective, safe prescribing and appropriate use of ACTs. For example, largely through USAID-funded initiatives, Management Sciences for Health supports malaria case management in Benin, Madagascar, Malawi, and Nigeria.

The program trains, mentors and evaluates health care providers how to buy kamagra in usa on the use of national malaria treatment guidelines. Take action today to maximize the longevity of ACTs. The battle to delay artemisinin drug resistance must be fought on two fronts. The first is to support the use how to buy kamagra in usa of quality-assured medicines at the correct dosage and to continually monitor their therapeutic efficacy against any emerging signs of resistance.

The second is to support national malaria programs to adopt and deploy more than one artemisinin-based treatment, such as second-line or even multiple first-line therapies along with the addition of single low-dose primaquine to help block the transmission of resistant parasites, in line with WHO guidance. Strategies such as adding a third drug to an ACT—forming a triple ACT, or TACT—are also being investigated. Finally, we need how to buy kamagra in usa to acknowledge that the sun may be setting on today's drugs. It may be a long sunset, but we need to be ready for tomorrow.

Develop the next generation of treatments. Medicines for Malaria Venture (MMV), a not-for-profit research and development organization, and its research and pharma partners how to buy kamagra in usa have developed the largest portfolio of antimalarials in history. The most advanced new antimalarial medicine targeting parasites showing resistance to current drugs is in development with Swiss health care company Novartis. It's currently in clinical trials and is aimed at treating children as young as six months, as malaria kills more children under five than any other age group.

National malaria control programs must be ready to incorporate this how to buy kamagra in usa potential new medicine in their budgets and treatment guidelines when it becomes available. Expand lab testing capacity. Improved surveillance to track the spread of resistant plasmodia is critical to maintaining progress, including using molecular and genomic techniques. However, many sub-Saharan African countries how to buy kamagra in usa do not yet have the equipment, personnel, funding or infrastructure to efficiently handle sequencing for malaria.

Here, too, investors and collaborators must strengthen and build additional capacity. The National Institutes of Health and the Wellcome Trust have established the Human Heredity and Health in Africa (H3Africa) initiative to build capacity on the continent, as is the U.S. President’s Malaria Initiative–supported Antimalarial Resistance Monitoring in Africa Network, which also supports how to buy kamagra in usa collaborative efforts across the continent. The Africa CDC and the African Academy of Sciences have provided funding.

Yet much more is needed for sufficient lab capacity. Develop how to buy kamagra in usa a cross-border action plan with neighboring countries. Now that resistant parasites have been documented in Rwanda, they may be carried by travelers across borders or may already be in other African countries. National malaria control programs and WHO’s regional and country offices need to reinforce intercountry collaboration, sharing information as well as educating health care providers and communities about the implications of the mutation.

Pharmaceutical regulatory agencies should continue to monitor how to buy kamagra in usa and enforce quality standards to prevent and tackle substandard and falsified medicines, which greatly contribute to drug resistance. The West African Health Organization. Southern African Development Community. And East, Central and how to buy kamagra in usa Southern African Health Community should work together to align efforts.

Southeast Asia has already seen this mutation as of 2013 and is holding it at bay with careful use of drugs that work where they are most needed. We can outsmart this. We must bring our collective human ingenuity and determination to ensure that the continent bearing the world’s greatest burden of malaria stays one step ahead of the emerging threat of this dangerous mutant parasite..

GPT-3 demonstrates a broader trend in artificial intelligence where can i buy kamagra oral jelly. Deep learning, which has in recent years become the dominant technique for creating new AIs, uses enormous amounts of data and computing power to fuel complex, accurate models. These resources are more accessible for researchers at large companies and elite universities. As a result, a study from Western University suggests, there has been where can i buy kamagra oral jelly a "de-democratization" in AI. The number of researchers able to contribute to cutting-edge developments is shrinking.

This narrows the pool of people who are able to define the research directions for this pivotal technology, which has social implications. It may even be contributing to some of the ethical challenges facing AI development, where can i buy kamagra oral jelly including privacy invasion, bias and the environmental impact of large models. To combat these problems, researchers are trying to figure out how to do more with less. One such recent advance is called “less than one”–shot learning (LO-shot learning), developed by Ilia Sucholutsky and Matthias Schonlau from the University of Waterloo.[Office1] [RK2] The principle behind LO-shot learning is that it should be possible for an AI to learn about objects in the world without being fed an example of each one. This has been a major hurdle for contemporary AI systems, which often require thousands of examples to where can i buy kamagra oral jelly learn to distinguish objects.

Humans, on the other hand, are often able to abstract away from existing examples in order to recognize new never-before-seen items. For example, when shown different shapes, a child is able to easily distinguish between the examples and to recognize the relationships between what they were shown and new shapes. The team first where can i buy kamagra oral jelly introduced this sort of learning through a process called soft distillation. An image database maintained by the National Institute for Standards and Technology, called MNIST, which contains 60,000 examples of written digits from 0 to 9, was distilled down to five images that blended features of the various numbers. After being shown only those five examples, the University of Waterloo system was able to accurately classify 92 percent of the remaining images in the database.

In their latest paper, the team has extended this where can i buy kamagra oral jelly principle to show that, theoretically, LO-shot techniques allow AIs to potentially learn to distinguish thousands of objects given a small data set of even two examples. This is a great improvement on traditional deep-learning systems, in which the demand for data grows exponentially with the need to distinguish more objects. Currently, LO-shot’s small data sets need to be carefully engineered to distill the features of the various classes of objects. But Sucholutsky is seeking to further develop this work by looking at where can i buy kamagra oral jelly the relationships between objects already captured in existing small data sets. Allowing AIs to learn with considerably less data is important for several reasons.

First, it better encapsulates the actual process of learning by forcing the system to generalize to classes it has not seen. By building in abstractions that capture the relationships where can i buy kamagra oral jelly between objects, this technique also reduces the potential for bias. Currently, deep-learning systems fall prey to bias arising from irrelevant features in the data they use to train. A well-known example of this problem is that AI classifies dogs as wolves when shown images of dogs in a snowy environment—because most images of wolves feature them near snow. Being able where can i buy kamagra oral jelly to zero in on relevant aspects of the image would help prevent these mistakes.

Reducing data needs thus makes these systems less liable to this sort of bias. Next, the less extensive the data one needs to use, the less incentive exists to surveil people to build better algorithms. For example, soft where can i buy kamagra oral jelly distillation techniques have already impacted medical AI research, which trains its models using sensitive health information. In one recent paper, researchers used soft distillation in diagnostic x-ray imagery based on a small, privacy-preserving data set. Finally, allowing AIs to learn with less plentiful data helps to democratize the field of artificial intelligence.

With smaller AIs, academia can remain relevant and avoid where can i buy kamagra oral jelly the risk of professors being poached by industry. Not only does LO-shot learning make the barriers to entry lower by reducing training costs and lowering data requirements, but it also provides more flexibility for users to create novel data sets and experiment with new approaches. By reducing the time spent on data and architecture engineering, researchers looking to leverage AI can spend more time focusing on the practical problems they are aiming to solve.1971 Antievolution Evolves “In recent months the teaching of evolution has come under attack in a number of states. The revival of fundamentalism in biology takes where can i buy kamagra oral jelly a somewhat new form. The emphasis is on opposition to current theories of the origin of life and the diversity of species not by theologians but by scientists.

The movement is led by the Creation Research Society, whose members have appeared before state boards of education and textbook committees in California, Texas, Arkansas and Tennessee. The society's credo says that it is ‘committed to full belief in the Biblical record of creation and where can i buy kamagra oral jelly early history’ and that its goal is ‘the realignment of science based on theistic creation concepts.’” Joy of Pulsars “The origin of the energy input to the Crab Nebula had been a puzzle that had long defied attempts at solution. Among the various possibilities considered, John Archibald Wheeler at Princeton in 1966 and Franco Pacini at Cornell in 1967 had independently put forward the apparently far-fetched idea that a rotating neutron star might be the energy source. Now, after the fact, it is possible to use the observations of the Crab Nebula and its pulsar (NP0531) to invert the problem and show that if the pulsar is a rotating star, it must have the mass and radius of a neutron star. In other words, even without the theory developed over where can i buy kamagra oral jelly the past 40 years, it is possible to assert that stars of approximately one solar mass and radii on the order of 10 kilometers must exist since the pulsar in the Crab Nebula is such a star.

€”Jeremiah P. Ostriker” 1921 Truck Transport “This is the era of the motor truck. Yesterday it was the where can i buy kamagra oral jelly railroad. Before that it was the stage coach. And still further back it was the canal.

The motor truck, and where can i buy kamagra oral jelly by that we mean modern highway transportation, has come into its own. It has defined its field of service and established itself therein. In the field of short-haul transportation, the motor truck is the last word in efficiency. The use of the motor truck, both in the handling of passengers and freight, is entirely an economic proposition for the benefit, according to the leading motor truck authorities, of the country at large where can i buy kamagra oral jelly. If that is so, there is no justification for limiting by legislation the use of the highway by that vehicle.” Connecting Coast to Coast “The Longest Land Line in the United States was recently opened to the public by the Western Union Telegraph Company, giving direct communication between New York and Seattle.

Four messages simultaneously each way can be sent over the single copper strand.” 1871 Thomas Henry Huxley “Although Dr. Huxley is profoundly learned in natural history, he has also found time where can i buy kamagra oral jelly for general literary culture, and is fond of poetry, fiction, and fine writing. It is this wide culture that gives him such power in his controversial writings. He seems to like nothing better than a regular set-to with some members of the old-school scientists, and he has sometimes been accused of exhibiting a pugnacious and acrimonious spirit. On one occasion Samuel Wilberforce, Bishop of Oxford, blandly asked him in the presence of a large audience.

€˜Is the learned gentleman really willing to have it go forth to the world that he believes himself to be descended from a where can i buy kamagra oral jelly monkey?. €™ Professor Huxley rose and replied in his quiet manner, ‘Whether I should be descended from a respectable monkey, or from a bishop of the English church, who can put his brains to no better use than to ridicule science and misrepresent its cultivators, I would certainly choose the monkey!. €™â€ Camels in Nevada “On a ranch on the Carson river is to be seen a herd of twenty-six camels, all but two of which were born and raised in this State. The camel may now be said to be acclimated to Nevada where can i buy kamagra oral jelly. The ranch upon which they are kept is sandy and sterile in the extreme, yet the animals feast and grow fat on such prickly shrubs and bitter weeds as no other animal would touch.

When left to themselves, their great delight, after filling themselves with the coarse herbage of the desert, is to lie and roll in the hot sand. They are used in packing salt to the mills on the river, from the marshes lying where can i buy kamagra oral jelly in the deserts, some sixty miles to the eastward. Some of the animals easily pack 1,100 pounds.”Ever since the deadly parasite responsible for malaria was discovered in the late 19th century, science and global health experts have been waging a vigorous Sisyphean battle against the disease it causes. Humans have brought an arsenal of tools—nets, rapid tests, medication—to bear against the mosquito-borne parasite, which cannily mutates to become resistant to drug treatments. We’re holding where can i buy kamagra oral jelly our own.

Global malaria deaths declined to 409,000 in 2019, compared to 585,000 in 2010, and a number of countries have eliminated it altogether or are on the verge of doing so. However, more than 90 percent of the deaths occur in Africa, and there is a threat that could set progress back again. Researchers in Rwanda identified a strain of the malaria where can i buy kamagra oral jelly parasite P. Falciparum with mutations on a gene known as K13 that enable resistance to artemisinin, the foundation of artemisinin-based combination therapies (ACTs), the most commonly used malaria treatments. While ACTs still work, a weakened treatment regimen could lead to more deaths on the continent, an increased spread of resistance itself, and loss of confidence in malaria treatment.

We must act now to increase where can i buy kamagra oral jelly surveillance and monitoring for signs of new K13 mutations, even as we battle the erectile dysfunction treatment kamagra. In addition to basic tactics like increasing people’s access to insecticide-treated mosquito nets, here’s what can help make a difference. Ensure that providers and patients use drugs effectively. When providers don’t prescribe treatments correctly or their where can i buy kamagra oral jelly patients don’t take the complete course as prescribed, it contributes to the emergence of drug-resistant malaria parasites. Governments and global health programs need to reinforce effective, safe prescribing and appropriate use of ACTs.

For example, largely through USAID-funded initiatives, Management Sciences for Health supports malaria case management in Benin, Madagascar, Malawi, and Nigeria. The program trains, mentors and evaluates health care providers on the use of national malaria where can i buy kamagra oral jelly treatment guidelines. Take action today to maximize the longevity of ACTs. The battle to delay artemisinin drug resistance must be fought on two fronts. The first is to support the use of quality-assured medicines at the correct dosage and where can i buy kamagra oral jelly to continually monitor their therapeutic efficacy against any emerging signs of resistance.

The second is to support national malaria programs to adopt and deploy more than one artemisinin-based treatment, such as second-line or even multiple first-line therapies along with the addition of single low-dose primaquine to help block the transmission of resistant parasites, in line with WHO guidance. Strategies such as adding a third drug to an ACT—forming a triple ACT, or TACT—are also being investigated. Finally, we need to acknowledge that the where can i buy kamagra oral jelly sun may be setting on today's drugs. It may be a long sunset, but we need to be ready for tomorrow. Develop the next generation of treatments.

Medicines for Malaria where can i buy kamagra oral jelly Venture (MMV), a not-for-profit research and development organization, and its research and pharma partners have developed the largest portfolio of antimalarials in history. The most advanced new antimalarial medicine targeting parasites showing resistance to current drugs is in development with Swiss health care company Novartis. It's currently in clinical trials and is aimed at treating children as young as six months, as malaria kills more children under five than any other age group. National malaria control programs must be ready to incorporate this potential where can i buy kamagra oral jelly new medicine in their budgets and treatment guidelines when it becomes available. Expand lab testing capacity.

Improved surveillance to track the spread of resistant plasmodia is critical to maintaining progress, including using molecular and genomic techniques. However, many sub-Saharan African countries do not yet have the equipment, personnel, funding or infrastructure to efficiently handle where can i buy kamagra oral jelly sequencing for malaria. Here, too, investors and collaborators must strengthen and build additional capacity. The National Institutes of Health and the Wellcome Trust have established the Human Heredity and Health in Africa (H3Africa) initiative to build capacity on the continent, as is the U.S. President’s Malaria Initiative–supported Antimalarial Resistance Monitoring in Africa Network, which also where can i buy kamagra oral jelly supports collaborative efforts across the continent.

The Africa CDC and the African Academy of Sciences have provided funding. Yet much more is needed for sufficient lab capacity. Develop a cross-border action plan where can i buy kamagra oral jelly with neighboring countries. Now that resistant parasites have been documented in Rwanda, they may be carried by travelers across borders or may already be in other African countries. National malaria control programs and WHO’s regional and country offices need to reinforce intercountry collaboration, sharing information as well as educating health care providers and communities about the implications of the mutation.

Pharmaceutical regulatory where can i buy kamagra oral jelly agencies should continue to monitor and enforce quality standards to prevent and tackle substandard and falsified medicines, which greatly contribute to drug resistance. The West African Health Organization. Southern African Development Community. And East, where can i buy kamagra oral jelly Central and Southern African Health Community should work together to align efforts. Southeast Asia has already seen this mutation as of 2013 and is holding it at bay with careful use of drugs that work where they are most needed.

We can outsmart this. We must bring our collective human ingenuity and determination to ensure that the continent bearing the world’s greatest burden of malaria stays one step ahead of the emerging threat of this dangerous mutant parasite..

What may interact with Kamagra?

Do not take Kamagra with any of the following:

  • cisapride
  • methscopolamine nitrate
  • nitrates like amyl nitrite, isosorbide dinitrate, isosorbide mononitrate, nitroglycerin
  • nitroprusside
  • other sildenafil products (Caverta, Silagra, Eriacta, etc.)

Kamagra may also interact with the following:

  • certain drugs for high blood pressure
  • certain drugs for the treatment of HIV or AIDS
  • certain drugs used for fungal or yeast s, like fluconazole, itraconazole, ketoconazole, and voriconazole
  • cimetidine
  • erythromycin
  • rifampin

This list may not describe all possible interactions. Give your health care providers a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

Buy kamagra jelly australia

The U.S buy kamagra jelly australia http://thepeoplesadjustmentfirm.com/?page_id=93. Department of Agriculture’s National Institute of Food and Agriculture (NIFA) announced recently departments across the country were receiving nearly $25 million in grants to support projects aimed to alleviate stress for agricultural workers. The 50 grants support programs ranging from preventing buy kamagra jelly australia suicide to marriage and relationship counseling.

“NIFA’s Farm and Ranch Stress Assistance Network connects farmers, ranchers and others in agriculture-related occupations to stress assistance programs,” said NIFA Director Dr. Carrie Castille in buy kamagra jelly australia a statement. €œCreating and expanding a network to assist farmers and ranchers in times of stress can increase behavioral health awareness, literacy and positive outcomes for agricultural producers, workers and their families.” NIFA says that even before the kamagra effects on the agricultural sector, stress was on the rise among those in the industry.

Ray Atkinson is the spokesman for the American Farm Bureau Federation. The organization runs a Farm State of buy kamagra jelly australia Mind campaign, which includes research, a directory of resources, training, and tips on starting a conversation. Though they are not direct beneficiaries of the grant, they work with many of the grant recipients.

“It sounds cliche, but…it’s totally true that it’s OK not to be OK,” Atkinson said in a Zoom interview buy kamagra jelly australia with The Daily Yonder. €œFarmers help farmers. We know farmers help farmers, and so it’s about really just encouraging folks to look out for neighbors, friends, and family.

And just start this buy kamagra jelly australia conversation. Just be there. Be willing to be there for people.” During the height of the kamagra, in January 2021, the American Farm Bureau released a survey that found a majority of farmers and farmworkers said the erectile dysfunction treatment kamagra had impacted their mental health, and more than half said they were personally experiencing more mental health challenges than they were a year buy kamagra jelly australia before then.

Like this story?. Sign up for our newsletter. “My takeaway from this survey is that the need for support is real and we must not allow lack of access or a ‘too tough to need help’ mentality to stand in the way,” said AFBF President Zippy Duvall at the buy kamagra jelly australia time of the release of the survey.

“We are stepping up our efforts through our Farm State of Mind campaign, encouraging conversations about stress and mental health and providing free training and resources for farm and ranch families and rural communities.” In Minnesota, NIFA awarded the State Department of Agriculture $500,000 for its Bend, Don’t Break project. The project will buy kamagra jelly australia engage agency, nonprofit, and educational partners in helping farmers and others in agriculture cope with adversity, addressing suicide, farm transition/succession, legal problems, family relationships and youth stress. Some of the organizations are legacy organizations, said Meg Moynihan, senior advisor on Strategy &.

Innovation at the Minnesota Department buy kamagra jelly australia of Agriculture. “We think our farmers are far more likely to be receptive to groups and organizations they already know,” she said in a phone interview. One such program is a network of mostly retired farmers, who act as advocates for current farmers experiencing hardships.

They currently have 10 farmer advocates across the state and will be hiring one more, buy kamagra jelly australia she said. There is also money earmarked toward non-traditional farmers, which includes immigrant farmers. €œWe have quite a substantial and growing number of Latino and buy kamagra jelly australia Hispanic farmers,” Moynihan said.

€œPeople from Hmong origin, who have come from Laos and their family settled as refugees, or they themselves resettled and also attract new people from Africa, different countries in Africa.” Some projects will work specifically with Latino, Indigenous, and African farmers and farm workers. As the results of the survey showed, Moynihan said stress has increased due to the kamagra for a variety of reasons, including market fluctuations and supply disruptions, familiar strains, and more. “During the kamagra, families were thrown together buy kamagra jelly australia in a way that they aren’t usually thrown together,” she said.

€œIn some cases, the spouse who worked on a farm and was bringing in crucial income and benefits to the farm, perhaps was furloughed or their business closed, or their hours were severely cut. And so that presented some financial challenges to the farm.” To help with family-related issues, the Minnesota buy kamagra jelly australia Department of Agriculture will be funding a series of retreats for farm couples to have firsthand experience with a psychologist and facilitators to work through issues, she said. The retreats are for “people who are finding their relationships balancing in different ways and want to explore that.” You Might Also LikeEnlarge this image The Oneida Indian Nation unveiled a cultural art installation called "Passage of Peace," which features nine illuminated tipis seen off the New York State Thruway to raise awareness of the impact of erectile dysfunction treatment on Native Americans.

Oneida Indian Nation hide caption toggle caption Oneida Indian Nation The past year and a half have been stressful on many fronts for Chris Aragon, a caregiver for his older brother who has cerebral palsy. "The left side buy kamagra jelly australia of his body is atrophied and smaller than his right side, and he has trouble getting around. He's kind of like a big teenager," says Aragon, 60, who is part Apache and lives with his brother on the Fort Berthold Reservation of the Mandan, Hidatsa and Arikara Nation, in North Dakota.

His main goal throughout the kamagra has been to keep buy kamagra jelly australia his brother safe from erectile dysfunction treatment, and "it's really been a struggle," he says. The kamagra has been a financial stressor, too, says Aragon. He worked reduced hours last year, and had periods with no work recently.

"I'd wake up at night to go to the restroom, and then I wouldn't be able to go back to sleep." Aragon is among the 74% of American Indian and Alaska Natives who said someone in their household has struggled with depression, anxiety, stress buy kamagra jelly australia and problems with sleeping, in a recent poll by NPR, the Robert Wood Johnson Foundation and the Harvard T.H. Chan School of Public Health. Only 52% of white people said buy kamagra jelly australia the same.

Loading... erectile dysfunction treatment exacerbated long standing stresses created by historic inequities, says Spero Manson, who's Pembina Chippewa from North Dakota, and directs the University of Colorado's Centers for American Indian and Alaska Native Health buy kamagra jelly australia. Native communities in the United States have had higher rates of , are 3.3 times more likely to be hospitalized and more than twice as likely to die from the disease than whites.

And half of Native Americans in NPR's poll said they're facing serious financial problems. "As we struggle to address the sudden and precipitous added stresses posed by the hour by buy kamagra jelly australia the kamagra, it heightens that sense of pain, suffering of helplessness and hopelessness," says Manson. And it's manifesting in higher rates of anxiety, depression, post-traumatic stress disorder, he adds.

"I think the kamagra has definitely triggered this historical trauma that Native people do experience," says Adrianne Maddux, the executive director at Denver buy kamagra jelly australia Indian Health and Family Services, which runs a primary care clinic. She's witnessed a higher demand for behavioral health services, including addiction treatment. "Our therapists were inundated," kamagra tablets online says Maddux.

Responding to collective grief with collective support But buy kamagra jelly australia native communities also have unique strengths that have helped them approach the erectile dysfunction treatment crisis with resilience, says Manson. Tribes have responded to the kamagra with new initiatives to stay connected and support one another. "American and Alaska Native people, we are very social and collective in our understanding of who we are, how we reaffirm this sense of personhood and self," says Manson buy kamagra jelly australia.

"Some of the strength and resilience is in how collective and social these communities are." Part of the struggle in the kamagra has been "having a limited ability to get together and gather for things like powwows and ceremonies and other events that really keep us connected," says Victoria O'Keefe, a member of the Cherokee and Seminole Nations, and a psychologist at the Center for American Indian Health at Johns Hopkins University. And she adds, there's "collective grief, especially grief around losing elders and cultural keepers." But that collective mindset has also brought people together to heal. "We really buy kamagra jelly australia see so many communities mobilizing and are really determined to protect each other," says O'Keefe.

"This is driven by shared values across tribes such as connectedness, and living in relation to each other, living in relation to all living beings and our lands. And we protect our families, our buy kamagra jelly australia communities, our elders, our cultural keepers." That was evident in the Navajo Nation, says O'Keefe's colleague, Joshuaa Allison-Burbank, a member of the Navajo Nation and a speech language pathologist at the Center for American Indian Health. "This concept of Navajo of K'é," he says.

"It means family kinship ties." Enlarge this image Native tribes have responded buy kamagra jelly australia to the kamagra with creative ways to stay connected. Veronica Concho and Raymond Concho Jr. Grew traditional Pueblo foods and Navajo crops with their grandchildren Kaleb and Kateri Allison-Burbank in Waterflow, N.M.

Joshuaa Allison-Burbank hide caption toggle caption Joshuaa Allison-Burbank Allison-Burbank spent the early months of the kamagra working on the frontlines at a erectile dysfunction treatment care clinic of the Indian Health buy kamagra jelly australia Services in Shiprock, N.M. He says people were quick to start masking and social distancing. "That's what was so important for getting a grasp and controlling viral spread across the Navajo Nation was going back buy kamagra jelly australia to this concept with respect to other humans, respect to elders," says Allison-Burbank.

"It's also the concept of taking care of one another, taking care of the land." It also helped communities find creative solutions to other kamagra-related crises, like food shortages, he adds. Enlarge this image Left. Josiah Concho and his nephew Kaleb Allison-Burbank helped grow produce in Waterflow, N.M., buy kamagra jelly australia during the summer of last year.

They then gave the crops to native families in need. Right. Joshuaa Allison-Burbank and his family hung red chiles to dehydrate.

The excess produce helped combat food shortages in their communities. Joshuaa Allison-Burbank hide caption toggle caption Joshuaa Allison-Burbank Many people, including his own family, started farming and cooking traditional crops like corn and squash, which they previously ate only during traditional ceremonies. "My whole family, we were able to farm traditional Pueblo Foods and Navajo crops," says Allison-Burbank.

"And not just have enough for ourselves, but we had an abundance of to share with our extended family, our neighbors and to contribute to various mutual aid organizations." He says farming also allowed community members to spend more time together safely — which helped buffer some of the stress. Helping kids and elders navigate erectile dysfunction treatment fears Families also had more time to speak their native language and practice certain cultural routines, which he thinks helped people emotionally. Allison-Burbank, O'Keefe and their colleagues at the Center for American Indian Health also spearheaded an effort to help American Indian and Alaska Native children cope during the kamagra.

They wrote, published and distributed a children's story book called Our Smallest Warriors, Our Strongest Medicine. Overcoming erectile dysfunction treatment. Johns Hopkins Center for American Indian Health YouTube The book, which was illustrated by a native youth artist, tells the story of two kids whose mother is a health care worker treating people with erectile dysfunction treatment.

So, the kids turn to their grandmother, who helps them navigate their fears and anxieties. "Storytelling is an important and long standing tradition for tribal communities," says O'Keefe. "And we found that this was a way that we could weave together our shared cultural values across tribes, as well as public health guidance and mental health coping strategies to help native children and families." Over 70,000 copies of the book have been distributed across 100 tribes, says O'Keefe.

In addition to the book, parent resources and children's activities are available for free on the center's website. On the Berthold Reservation, where Aragon lives, he says tribal leaders were "very proactive" about supporting people with erectile dysfunction treatment and their families. "All [people] had to do was pick up the phone and call to get extra help, or get groceries brought to their house," he says.

Authorities also helped individuals with erectile dysfunction treatment isolate, using cabins at a local campground, so that they could minimize the risk of exposing other family members, he says. And people took the time to help the elderly, he adds. "They definitely treat their elders well here, and they're not just forgotten and put in a nursing home somewhere." Tribal youth in Minneapolis had similar efforts to take care of elders in their community, assisting them with getting food, medicine and other tasks, says Manson.

"This reflects an enormous sense of importance of elders in our communities as the repositories of cultural knowledge and our spiritual leaders," he says, as well as the importance of intergenerational relationships. Reaching across tribal boundaries The Oneida Indian Nation, which is located in upstate New York, recently unveiled an art installation to increase awareness about the disproportionate impact of the kamagra on Native communities as well as resources around erectile dysfunction treatment. Titled Passage of Peace, the installation features large tipis, which are traditional homes and gathering places.

The installation is located just off of the New York State Thruway, about midway between Syracuse and Utica. "We hope the Passage of Peace will bring attention to continued hardship taking place in many parts of Indian country, while delivering a message of peace and remembrance with our neighboring communities here in Upstate New York," says Ray Halbritter, Oneida Indian Nation Representative. Native communities are also connecting and supporting each other online, with projects like the Social Distance Powwow Facebook group, founded in March 2020 to "foster a space for community and cultural preservation." People from many different tribes share songs, dance videos, conversations, stories, and fundraisers and sell arts and crafts.

It now has over 278,000 members. The sense of community and respect for elders were also behind American Indian and Alaska Native people being more willing to get vaccinated to protect their communities, says Jennifer Wolf, founder of Project Mosaic, a consulting group for indigenous communities. "We have so many reasons to be mistrustful of a government that has taken land away from us and broken so many promises," says Wolf, "and yet we have the highest (erectile dysfunction treatment) vaccination rates in the country." According to the U.S.

Centers for Disease Control and Prevention, half of all American Indian and Alaska Native people have been fully vaccinated, and 60% have received at least one dose, as compared to only 42% and 47% respectively of all whites..

The U.S where can i buy kamagra oral jelly check this. Department of Agriculture’s National Institute of Food and Agriculture (NIFA) announced recently departments across the country were receiving nearly $25 million in grants to support projects aimed to alleviate stress for agricultural workers. The 50 where can i buy kamagra oral jelly grants support programs ranging from preventing suicide to marriage and relationship counseling.

“NIFA’s Farm and Ranch Stress Assistance Network connects farmers, ranchers and others in agriculture-related occupations to stress assistance programs,” said NIFA Director Dr. Carrie Castille in a statement where can i buy kamagra oral jelly. €œCreating and expanding a network to assist farmers and ranchers in times of stress can increase behavioral health awareness, literacy and positive outcomes for agricultural producers, workers and their families.” NIFA says that even before the kamagra effects on the agricultural sector, stress was on the rise among those in the industry.

Ray Atkinson is the spokesman for the American Farm Bureau Federation. The organization runs a Farm State of Mind campaign, which where can i buy kamagra oral jelly includes research, a directory of resources, training, and tips on starting a conversation. Though they are not direct beneficiaries of the grant, they work with many of the grant recipients.

“It sounds cliche, but…it’s totally true that it’s OK not to be OK,” Atkinson said in a Zoom interview with The Daily Yonder where can i buy kamagra oral jelly. €œFarmers help farmers. We know farmers help farmers, and so it’s about really just encouraging folks to look out for neighbors, friends, and family.

And just where can i buy kamagra oral jelly start this conversation. Just be there. Be willing to be there for people.” During the height of the kamagra, in January 2021, the American Farm Bureau released a survey that found where can i buy kamagra oral jelly a majority of farmers and farmworkers said the erectile dysfunction treatment kamagra had impacted their mental health, and more than half said they were personally experiencing more mental health challenges than they were a year before then.

Like this story?. Sign up for our newsletter. “My takeaway from this survey where can i buy kamagra oral jelly is that the need for support is real and we must not allow lack of access or a ‘too tough to need help’ mentality to stand in the way,” said AFBF President Zippy Duvall at the time of the release of the survey.

“We are stepping up our efforts through our Farm State of Mind campaign, encouraging conversations about stress and mental health and providing free training and resources for farm and ranch families and rural communities.” In Minnesota, NIFA awarded the State Department of Agriculture $500,000 for its Bend, Don’t Break project. The project will engage agency, nonprofit, and educational partners in helping farmers and others in agriculture cope with adversity, addressing suicide, farm transition/succession, where can i buy kamagra oral jelly legal problems, family relationships and youth stress. Some of the organizations are legacy organizations, said Meg Moynihan, senior advisor on Strategy &.

Innovation at the Minnesota Department where can i buy kamagra oral jelly of Agriculture. “We think our farmers are far more likely to be receptive to groups and organizations they already know,” she said in a phone interview. One such program is a network of mostly retired farmers, who act as advocates for current farmers experiencing hardships.

They currently have 10 farmer advocates across the state and will be hiring one where can i buy kamagra oral jelly more, she said. There is also money earmarked toward non-traditional farmers, which includes immigrant farmers. €œWe have where can i buy kamagra oral jelly quite a substantial and growing number of Latino and Hispanic farmers,” Moynihan said.

€œPeople from Hmong origin, who have come from Laos and their family settled as refugees, or they themselves resettled and also attract new people from Africa, different countries in Africa.” Some projects will work specifically with Latino, Indigenous, and African farmers and farm workers. As the results of the survey showed, Moynihan said stress has increased due to the kamagra for a variety of reasons, including market fluctuations and supply disruptions, familiar strains, and more. “During the kamagra, families were thrown together in where can i buy kamagra oral jelly a way that they aren’t usually thrown together,” she said.

€œIn some cases, the spouse who worked on a farm and was bringing in crucial income and benefits to the farm, perhaps was furloughed or their business closed, or their hours were severely cut. And so that presented some financial challenges to the farm.” To help with family-related issues, the Minnesota Department of Agriculture will be funding a series of retreats for farm couples to have firsthand experience where can i buy kamagra oral jelly with a psychologist and facilitators to work through issues, she said. The retreats are for “people who are finding their relationships balancing in different ways and want to explore that.” You Might Also LikeEnlarge this image The Oneida Indian Nation unveiled a cultural art installation called "Passage of Peace," which features nine illuminated tipis seen off the New York State Thruway to raise awareness of the impact of erectile dysfunction treatment on Native Americans.

Oneida Indian Nation hide caption toggle caption Oneida Indian Nation The past year and a half have been stressful on many fronts for Chris Aragon, a caregiver for his older brother who has cerebral palsy. "The left side of where can i buy kamagra oral jelly his body is atrophied and smaller than his right side, and he has trouble getting around. He's kind of like a big teenager," says Aragon, 60, who is part Apache and lives with his brother on the Fort Berthold Reservation of the Mandan, Hidatsa and Arikara Nation, in North Dakota.

His main goal throughout the kamagra has been to keep his brother safe from where can i buy kamagra oral jelly erectile dysfunction treatment, and "it's really been a struggle," he says. The kamagra has been a financial stressor, too, says Aragon. He worked reduced hours last year, and had periods with no work recently.

"I'd wake up at night to go to the restroom, and then I wouldn't be able to go back to sleep." Aragon is among the 74% of American Indian and Alaska Natives who said someone in their household has struggled with depression, anxiety, stress and problems with sleeping, in a recent poll by NPR, the Robert Wood Johnson where can i buy kamagra oral jelly Foundation and the Harvard T.H. Chan School of Public Health. Only 52% where can i buy kamagra oral jelly of white people said the same.

Loading... erectile dysfunction treatment exacerbated long standing stresses created by historic inequities, says Spero Manson, who's Pembina Chippewa from North Dakota, and directs the University of Colorado's Centers for American Indian where can i buy kamagra oral jelly and Alaska Native Health. Native communities in the United States have had higher rates of , are 3.3 times more likely to be hospitalized and more than twice as likely to die from the disease than whites.

And half of Native Americans in NPR's poll said they're facing serious financial problems. "As we where can i buy kamagra oral jelly struggle to address the sudden and precipitous added stresses posed by the hour by the kamagra, it heightens that sense of pain, suffering of helplessness and hopelessness," says Manson. And it's manifesting in higher rates of anxiety, depression, post-traumatic stress disorder, he adds.

"I think the kamagra has definitely triggered this historical trauma that Native people do experience," says Adrianne Maddux, the executive director at Denver where can i buy kamagra oral jelly Indian Health and Family Services, which runs a primary care clinic. She's witnessed a higher demand for behavioral health services, including addiction treatment. "Our therapists were kamagra oral jelly 100mg price inundated," says Maddux.

Responding to collective grief where can i buy kamagra oral jelly with collective support But native communities also have unique strengths that have helped them approach the erectile dysfunction treatment crisis with resilience, says Manson. Tribes have responded to the kamagra with new initiatives to stay connected and support one another. "American and Alaska Native people, we are very where can i buy kamagra oral jelly social and collective in our understanding of who we are, how we reaffirm this sense of personhood and self," says Manson.

"Some of the strength and resilience is in how collective and social these communities are." Part of the struggle in the kamagra has been "having a limited ability to get together and gather for things like powwows and ceremonies and other events that really keep us connected," says Victoria O'Keefe, a member of the Cherokee and Seminole Nations, and a psychologist at the Center for American Indian Health at Johns Hopkins University. And she adds, there's "collective grief, especially grief around losing elders and cultural keepers." But that collective mindset has also brought people together to heal. "We really see so many communities mobilizing and are really determined to where can i buy kamagra oral jelly protect each other," says O'Keefe.

"This is driven by shared values across tribes such as connectedness, and living in relation to each other, living in relation to all living beings and our lands. And we protect our families, our communities, our elders, our cultural keepers." That was evident in the Navajo Nation, says O'Keefe's colleague, Joshuaa Allison-Burbank, where can i buy kamagra oral jelly a member of the Navajo Nation and a speech language pathologist at the Center for American Indian Health. "This concept of Navajo of K'é," he says.

"It means family kinship ties." Enlarge this where can i buy kamagra oral jelly image Native tribes have responded to the kamagra with creative ways to stay connected. Veronica Concho and Raymond Concho Jr. Grew traditional Pueblo foods and Navajo crops with their grandchildren Kaleb and Kateri Allison-Burbank in Waterflow, N.M.

Joshuaa Allison-Burbank hide caption toggle caption Joshuaa Allison-Burbank Allison-Burbank where can i buy kamagra oral jelly spent the early months of the kamagra working on the frontlines at a erectile dysfunction treatment care clinic of the Indian Health Services in Shiprock, N.M. He says people were quick to start masking and social distancing. "That's what was so important for getting a grasp and controlling viral spread across the Navajo Nation was going back to this concept with respect to other humans, respect to where can i buy kamagra oral jelly elders," says Allison-Burbank.

"It's also the concept of taking care of one another, taking care of the land." It also helped communities find creative solutions to other kamagra-related crises, like food shortages, he adds. Enlarge this image Left. Josiah Concho and his where can i buy kamagra oral jelly nephew Kaleb Allison-Burbank helped grow produce in Waterflow, N.M., during the summer of last year.

They then gave the crops to native families in need. Right. Joshuaa Allison-Burbank and his family hung red chiles to dehydrate.

The excess produce helped combat food shortages in their communities. Joshuaa Allison-Burbank hide caption toggle caption Joshuaa Allison-Burbank Many people, including his own family, started farming and cooking traditional crops like corn and squash, which they previously ate only during traditional ceremonies. "My whole family, we were able to farm traditional Pueblo Foods and Navajo crops," says Allison-Burbank.

"And not just have enough for ourselves, but we had an abundance of to share with our extended family, our neighbors and to contribute to various mutual aid organizations." He says farming also allowed community members to spend more time together safely — which helped buffer some of the stress. Helping kids and elders navigate erectile dysfunction treatment fears Families also had more time to speak their native language and practice certain cultural routines, which he thinks helped people emotionally. Allison-Burbank, O'Keefe and their colleagues at the Center for American Indian Health also spearheaded an effort to help American Indian and Alaska Native children cope during the kamagra.

They wrote, published and distributed a children's story book called Our Smallest Warriors, Our Strongest Medicine. Overcoming erectile dysfunction treatment. Johns Hopkins Center for American Indian Health YouTube The book, which was illustrated by a native youth artist, tells the story of two kids whose mother is a health care worker treating people with erectile dysfunction treatment.

So, the kids turn to their grandmother, who helps them navigate their fears and anxieties. "Storytelling is an important and long standing tradition for tribal communities," says O'Keefe. "And we found that this was a way that we could weave together our shared cultural values across tribes, as well as public health guidance and mental health coping strategies to help native children and families." Over 70,000 copies of the book have been distributed across 100 tribes, says O'Keefe.

In addition to the book, parent resources and children's activities are available for free on the center's website. On the Berthold Reservation, where Aragon lives, he says tribal leaders were "very proactive" about supporting people with erectile dysfunction treatment and their families. "All [people] had to do was pick up the phone and call to get extra help, or get groceries brought to their house," he says.

Authorities also helped individuals with erectile dysfunction treatment isolate, using cabins at a local campground, so that they could minimize the risk of exposing other family members, he says. And people took the time to help the elderly, he adds. "They definitely treat their elders well here, and they're not just forgotten and put in a nursing home somewhere." Tribal youth in Minneapolis had similar efforts to take care of elders in their community, assisting them with getting food, medicine and other tasks, says Manson.

"This reflects an enormous sense of importance of elders in our communities as the repositories of cultural knowledge and our spiritual leaders," he says, as well as the importance of intergenerational relationships. Reaching across tribal boundaries The Oneida Indian Nation, which is located in upstate New York, recently unveiled an art installation to increase awareness about the disproportionate impact of the kamagra on Native communities as well as resources around erectile dysfunction treatment. Titled Passage of Peace, the installation features large tipis, which are traditional homes and gathering places.

The installation is located just off of the New York State Thruway, about midway between Syracuse and Utica. "We hope the Passage of Peace will bring attention to continued hardship taking place in many parts of Indian country, while delivering a message of peace and remembrance with our neighboring communities here in Upstate New York," says Ray Halbritter, Oneida Indian Nation Representative. Native communities are also connecting and supporting each other online, with projects like the Social Distance Powwow Facebook group, founded in March 2020 to "foster a space for community and cultural preservation." People from many different tribes share songs, dance videos, conversations, stories, and fundraisers and sell arts and crafts.

It now has over 278,000 members. The sense of community and respect for elders were also behind American Indian and Alaska Native people being more willing to get vaccinated to protect their communities, says Jennifer Wolf, founder of Project Mosaic, a consulting group for indigenous communities. "We have so many reasons to be mistrustful of a government that has taken land away from us and broken so many promises," says Wolf, "and yet we have the highest (erectile dysfunction treatment) vaccination rates in the country." According to the U.S.

Centers for Disease Control and Prevention, half of all American Indian and Alaska Native people have been fully vaccinated, and 60% have received at least one dose, as compared to only 42% and 47% respectively of all whites..

Kamagra nl opgelicht

The study this website of environmental determinants of health kamagra nl opgelicht is at a crossroads. Harmonised health data across cohorts followed over decades, novel technologies to gather information on health behaviours and location data, and high-resolution spatial data on environmental factors have made it possible for researchers to unearth insights and relationships never before possible. This special issue of Journal of Epidemiology and Community Health brings findings from collaborators in kamagra nl opgelicht the MINDMAP Project, an ambitious effort to examine the environmental determinants of mental health and well-being in older populations across Europe and Canada. The investigators involved in these studies have developed multiple high-resolution spatial datasets to examine a broad range of environmental factors, including area-level socioeconomic measures, crime, the built environment, green spaces and noise.

In addition, the MINDMAP collaboration enables validated and harmonised measures of mental health and well-being, including loneliness, depressive symptoms, antidepressant use, anxiety, affect and mental distress. But the true strength of the MINDMAP collaboration is the potential for innovation by applying diverse study designs, ranging from mobile health approaches to agent-based kamagra nl opgelicht modelling, to answer questions about how environmental factors drive healthy ageing. The findings presented unearth insights into potential environmental drivers of healthy ageing.Overview of MINDMAPWey et al provide an overview of the MINDMAP Project, which used longitudinal data from six cohort studies located in Eastern and Western Europe, as well as Canada, that comprised a total of 220 621 participants. Baseline years of these studies ranged from 1984 to 2012, with up to seven repeated data collection periods.

Looking across these studies, the investigators harmonised data on kamagra nl opgelicht 1848 environmental exposures and 993 individual-level determinants and health outcomes. The domains covered by these rich harmonised data include physical environments, sociodemographic factors, health behaviours, disease status, medication use, cognitive functioning, psychological assessments and social networks. The resulting harmonised multinational dataset was transparently kamagra nl opgelicht documented and stored on a central MINDMAP server for analysis.Introducing the complexity of ageing and well-being, Dapp et al capitalised on longitudinal MINDMAP data to examine the dynamics between depression, frailty and disability within an older cohort in Hamburg, Germany. The authors observed that depression increased the risk of subsequent frailty, and that frailty increased the risk of subsequent depression.

Interestingly, the investigators saw that while depression increased the risk of subsequent disability, disability was not associated with higher risk of subsequent depression. Dapp et al provide novel perspectives into the processes between ageing, mental health and disability, and offer suggestions kamagra nl opgelicht for increasing screening for depressed mood and functional decline to produce timely and targeted interventions.The importance of theoryTheory may sharpen predictions about how urban environments influence mental well-being in old age. There is a lack of consensus on even basic descriptive questions such as whether the prevalence of depressive symptoms rises with advancing age, and therefore inconsistencies in the empirical literature can only be reconciled and understood with the aid of good theory. In particular, multilevel studies of neighbourhood environments and mental health are often missing a third, higher, level of organisation, that is, the societal context in kamagra nl opgelicht which people live their lives.

This is only made possible by careful cross-national comparisons of harmonised data.To give a detailed example of what can be learnt from cross-national comparisons, a recent study contrasted suicide rates in Japan and South Korea, two neighbouring countries which share many superficial similarities (eg, rapid population ageing and high suicide rates overall), yet starkly different suicide rates at older ages.1 Applying age–period–cohort analysis of suicide trends between 1986 and 2015, Kino et al showed that there is a sharp increase in suicide around retirement age in Korea, but not in Japan (an age effect). Furthermore, there was a dramatic temporal increase in suicide during the three decades of observation in Korea (a period effect) whereas rates were relatively stable in Japan. Lastly, the post-World War II generation in Japan had lower rates of suicide kamagra nl opgelicht compared with generations born either before 1916 or after 1961 (birth cohort effect), whereas the suicide rate increased linearly with each generation in Korea. Japan provides a strong social safety net for the generation who contributed to the post-war period of economic expansion, while high suicide rates in Korea reflect the simultaneous decline of intergenerational care provision combined with inadequate social security in post-retirement.

Thus, although Japan and Korea share high overall suicide rates, careful cross-national comparative analysis points to divergent social policies as the basis for the stark differences in suicide at older ages. This example highlights how difficult it is to generalise about population kamagra nl opgelicht variability in mental health without an adequate understanding of the broader social context (particularly the social policy context) in which older adults lead their lives. Urban contexts are embedded within upstream social contexts. Hence, whether a research study conducted in country X confirmed/disconfirmed the findings of another study conducted in country Y is hard to interpret without considering the ‘missing level’ above urban neighbourhoods.Turning to the MINDMAP Project, Tarkiainen et al argue that the association between neighbourhood characteristics and mental health at older ages has produced inconsistent findings, possibly due to heterogeneity in the measurement of mental health outcomes, neighbourhood characteristics and confounders.

In their cross-national comparative study, which harmonised measures of exposures, outcomes and confounders across three countries—Finland, Sweden and Italy—the authors found that dense and mixed urban structure was associated with higher antidepressant use at older ages in Stockholm and kamagra nl opgelicht in Finland, but not in Italy. In other words, their study buttresses the idea that there is something more going on than measurement and study design issues, and heterogeneity of treatment effects might be expected depending on the social context. Tarkiainen et al speculate that their mixed finding might be explained by differences in family solidarity (a cultural characteristic) between the countries, viz kamagra nl opgelicht. Italy is characterised by strong family responsibility for older people while contact with elderly parents may be looser in the Nordic countries (Indeed, the frequency of intergenerational contact has been put forward as one of the reasons why Italy suffered one of the worst erectile dysfunction treatment outbreaks in Europe.2).

Future studies might attempt to incorporate these measures of social context into analysis to better understand the mechanisms at play.Improving exposure assessmentExposure assessment is at the crux of research on environmental drivers of health. Accurate exposure assessment that reflects personal exposure during a relevant time window allows for more precise estimation of kamagra nl opgelicht the relationship between an environmental factor and healthy ageing. Conversely, non-differential measurement error is likely to bias results towards the null.3 Therefore, if the exposures estimated across the studies in this special issue contain non-differential error, it is possible that this error accounts for the majority of null findings.While evidence is growing that environmental factors may drive mental health and well-being as we age, limitations in exposure assessment are the largest barriers to advancing the field. Poorly measured exposure data do not allow us to determine aetiologically relevant exposures in a way that is actionable by individuals or communities.

Coarse exposure assessment limits statements about causal inference and provides little information on potential interventions for policymakers.4 5This lack of kamagra nl opgelicht consistency in defining exposures could be at play in the study by Tarkiainen et al, where the authors observed inconsistent associations for antidepressant use by levels of urbanicity, land use mix, and population density across areas of Sweden, Finland and Italy. The definition of dense urban structure may differ greatly in Sweden and Finland compared with Italy. Are dense neighbourhoods monolithic apartment complexes or mixed-use kamagra nl opgelicht vibrant communities?. While both scenarios would constitute high density, the lack of a well-defined exposure makes it difficult to discern what the true exposure is that might drive antidepressant use.

In addition, urbanicity is defined as ‘proportion of continuous urban fabric’. How would one design a randomised trial kamagra nl opgelicht to experimentally expose someone to ‘urbanicity’?. And, assuming urbanicity does cause antidepressant use, how would researchers advise policymakers on how to change urbanicity?. Do we remove kamagra nl opgelicht pavement?.

Knock down buildings?. Plant trees?. Broadly defined exposures create confusion in understanding exactly what causal question kamagra nl opgelicht we are asking.Similarly, other studies used non-specific measures of the built environment in analyses, including Ruiz et al, Sund et al and Noordzij et al. Noordzij et al define exposure to green space based on the distance between a participant’s residential address and the nearest green space using data from the Urban Atlas dataset, which contains comparable land use and land cover data across Europe.

The use of a harmonised green space metric allows for pooling of the data across all four cohorts. However, the downside is that we have no information on the specific type of green space kamagra nl opgelicht involved. Are grassy meadows comparable with wooded forests?. Are urban parks kamagra nl opgelicht comparable with suburban parks?.

The combination of these dissimilar green spaces, where some may positively influence depressive symptoms and others might not, contributes to exposure misclassification. The authors in Sund et al mention that urban areas provide an urban penalty by increasing exposure to air pollution, noise or violence, or conversely, may provide an urban advantage by providing higher access to cultural activities or social networks. Future MINDMAP studies should measure and estimate the effects of these specific factors on kamagra nl opgelicht health.Timmermans et al conducted an analysis on land use and loneliness in older adults from a cross-sectional analysis of two Dutch cohorts. In the time of erectile dysfunction treatment and increased social distancing, understanding environmental drivers of loneliness is all the more important.

The authors find some suggestion that participants living in areas with higher land use mix had lower levels of loneliness, although this finding was not statistically significant. The authors proffer that land use mix could reflect ‘the availability of various destinations and neighbourhood resources in kamagra nl opgelicht the local living environment’. However, land use mix could also be correlated with other factors, such as access to transit, access to green spaces or even something as simple as street benches, which encourage social interaction. Future research could engage multiexposure models to isolate which specific factor appears to have the greatest impact on kamagra nl opgelicht loneliness.Li et al evaluated whether a noise mitigation policy in Amsterdam led to an improvement in mental health.

There are theoretical and empirical reasons why noise can affect residents’ mental health (not the least through sleep disruption). From an exposure assessment perspective, one of the things that researchers seldom bother to assess is how do the residents perceive noise. When people appraise the noise as unpredictable, beyond their control and not to kamagra nl opgelicht their benefit, the mental health impacts are much worse. If, however, there are more positive appraisals (eg, residents have been told that the noise will last for a specified duration of time and is associated with some community benefit—for example, the construction of an attractive neighbourhood amenity—the mental health impacts will be less).

Self-reported data on noise perceptions, as well as control over noise, would be a worthwhile addition to the MINDMAP Project.Technological advances to address gapsRecent technological advances have provided researchers with tools that can fill many research gaps outlined above. We have new tools to estimate high-resolution metrics of mobility, human behaviour and psychological processes that occur within kamagra nl opgelicht a day. Fernandes et al describe the development of a study that incorporates multiple tools for innovative perspectives on these factors. Their research protocol combines global positioning kamagra nl opgelicht systems and accelerometer data, proximity detection to assess whether household members are close to each other for objective measures of social interactions, ecological momentary assessment prompts up to eight times per day to track momentary mood and stress and environmental perceptions, and electrodermal activity for the potential objective prediction of stress.

These technologies provide moment-to-moment data on how environmental factors influence mood and stress, as well as how these relationships are impacted by social interaction, to provide a thorough understanding of the dynamic processes through which environmental exposures may drive mood changes. Important studies such as this will unveil exciting perspectives on the fine-scale mechanisms at play and will fill gaps in the literature, which has previously focused on infrequent measurement of mental health outcomes (eg, every 2 years) or residence-based exposure assessment.In addition to these high-resolution measures of mobility and psychological processes, we now have access to spatial dataset that provides information on the environment in ways never before seen. Ubiquitous georeferenced street-level imagery, such as Google Street View, provides detailed, time-varying information on specific small-scale environmental factors.6 7 Recent advances in deep learning have made it possible for researchers to rigorously and systematically evaluate these images for exposure assessment at scale.8 We can now tease kamagra nl opgelicht out exactly what is in each image, such as sidewalk availability or tree species, and link these images to the locations that they were gathered. These images have also been gathered for over a decade, so that we can evaluate how environments change over time.

As mentioned above, measuring specific, time-varying environmental features has been challenging, and has hindered the ability of previous studies to isolate key health-promoting features of the environment. Applying deep learning to street-level images empowers kamagra nl opgelicht the measurement of environmental factors in a high-resolution, specific, consistent and scalable manner across large areas. Linking these measures to health will reveal policy-relevant and actionable information on how to optimise environments for mental health and well-beingModelling policy impactsUltimately, the goal of research on the environmental drivers of healthy ageing is to identify potential interventions and estimate how these interventions influence health outcomes. To this end, Yang et al employed an agent-based model to evaluate the impact of a kamagra nl opgelicht free bus policy on both public transit use, as well as depression among older adults.

They benchmarked this model against empirical data from England and ran several simulations to examine different policy scenarios. The authors’ model predicted that free bus policies lead to increased bus usage and decreased depression. In addition, improving attitudes towards the bus could enhance the effects of a kamagra nl opgelicht free bus policy, particularly for those living close to public transit, as well as in scenarios where poorer populations live close to the city centre. Although these agent-based models contain substantial assumptions, they provide crucial information to decision makers to enact policies that maximise health.

Agent-based models also highlight the factors that may modulate the effectiveness of environmental interventions, which may indicate the need for multiscale interventions for optimal outcomes.Commentary on the MINDMAP ProjectWith all of the effort that went into harmonising exposure, outcomes and other core measures across six cohorts spanning seven countries (Wey et al), the findings gathered in this special issue provide novel cross-national findings. The MINDMAP collaboration has laid a groundwork for future research to harmonise environmental exposure data and health outcome information in multiple large studies across countries in Europe. The initial offering from the MINDMAP Project is only the beginning. Perhaps the best is yet to come..

The study of environmental determinants of http://cheaper-hotels.dk/where-can-i-buy-zithromax-z-pak/ health where can i buy kamagra oral jelly is at a crossroads. Harmonised health data across cohorts followed over decades, novel technologies to gather information on health behaviours and location data, and high-resolution spatial data on environmental factors have made it possible for researchers to unearth insights and relationships never before possible. This special issue of where can i buy kamagra oral jelly Journal of Epidemiology and Community Health brings findings from collaborators in the MINDMAP Project, an ambitious effort to examine the environmental determinants of mental health and well-being in older populations across Europe and Canada. The investigators involved in these studies have developed multiple high-resolution spatial datasets to examine a broad range of environmental factors, including area-level socioeconomic measures, crime, the built environment, green spaces and noise. In addition, the MINDMAP collaboration enables validated and harmonised measures of mental health and well-being, including loneliness, depressive symptoms, antidepressant use, anxiety, affect and mental distress.

But the true strength of the MINDMAP collaboration is the potential for innovation by applying diverse study designs, ranging from mobile health approaches to agent-based modelling, to answer where can i buy kamagra oral jelly questions about how environmental factors drive healthy ageing. The findings presented unearth insights into potential environmental drivers of healthy ageing.Overview of MINDMAPWey et al provide an overview of the MINDMAP Project, which used longitudinal data from six cohort studies located in Eastern and Western Europe, as well as Canada, that comprised a total of 220 621 participants. Baseline years of these studies ranged from 1984 to 2012, with up to seven repeated data collection periods. Looking across these studies, the investigators harmonised data on 1848 environmental exposures and where can i buy kamagra oral jelly 993 individual-level determinants and health outcomes. The domains covered by these rich harmonised data include physical environments, sociodemographic factors, health behaviours, disease status, medication use, cognitive functioning, psychological assessments and social networks.

The resulting harmonised multinational dataset was transparently documented and stored on a central MINDMAP server for analysis.Introducing the complexity of ageing and well-being, Dapp et al capitalised on longitudinal MINDMAP data to examine the dynamics between depression, frailty and disability within an older cohort where can i buy kamagra oral jelly in Hamburg, Germany. The authors observed that depression increased the risk of subsequent frailty, and that frailty increased the risk of subsequent depression. Interestingly, the investigators saw that while depression increased the risk of subsequent disability, disability was not associated with higher risk of subsequent depression. Dapp et al provide novel perspectives into the processes between ageing, mental health and disability, and offer suggestions for increasing screening for depressed mood where can i buy kamagra oral jelly and functional decline to produce timely and targeted interventions.The importance of theoryTheory may sharpen predictions about how urban environments influence mental well-being in old age. There is a lack of consensus on even basic descriptive questions such as whether the prevalence of depressive symptoms rises with advancing age, and therefore inconsistencies in the empirical literature can only be reconciled and understood with the aid of good theory.

In particular, multilevel studies of neighbourhood environments and mental health are often missing a third, higher, level of organisation, that is, the societal context where can i buy kamagra oral jelly in which people live their lives. This is only made possible by careful cross-national comparisons of harmonised data.To give a detailed example of what can be learnt from cross-national comparisons, a recent study contrasted suicide rates in Japan and South Korea, two neighbouring countries which share many superficial similarities (eg, rapid population ageing and high suicide rates overall), yet starkly different suicide rates at older ages.1 Applying age–period–cohort analysis of suicide trends between 1986 and 2015, Kino et al showed that there is a sharp increase in suicide around retirement age in Korea, but not in Japan (an age effect). Furthermore, there was a dramatic temporal increase in suicide during the three decades of observation in Korea (a period effect) whereas rates were relatively stable in Japan. Lastly, the post-World War II generation in Japan had lower rates of suicide compared with generations born either before 1916 or after 1961 (birth cohort effect), whereas the suicide where can i buy kamagra oral jelly rate increased linearly with each generation in Korea. Japan provides a strong social safety net for the generation who contributed to the post-war period of economic expansion, while high suicide rates in Korea reflect the simultaneous decline of intergenerational care provision combined with inadequate social security in post-retirement.

Thus, although Japan and Korea share high overall suicide rates, careful cross-national comparative analysis points to divergent social policies as the basis for the stark differences in suicide at older ages. This example highlights how difficult it is to generalise about where can i buy kamagra oral jelly population variability in mental health without an adequate understanding of the broader social context (particularly the social policy context) in which older adults lead their lives. Urban contexts are embedded within upstream social contexts. Hence, whether a research study conducted in country X confirmed/disconfirmed the findings of another study conducted in country Y is hard to interpret without considering the ‘missing level’ above urban neighbourhoods.Turning to the MINDMAP Project, Tarkiainen et al argue that the association between neighbourhood characteristics and mental health at older ages has produced inconsistent findings, possibly due to heterogeneity in the measurement of mental health outcomes, neighbourhood characteristics and confounders. In their cross-national comparative study, which harmonised measures of exposures, outcomes and confounders across three countries—Finland, Sweden and Italy—the authors found that dense and mixed urban structure was associated with higher antidepressant use at older ages in Stockholm and in Finland, but not where can i buy kamagra oral jelly in Italy.

In other words, their study buttresses the idea that there is something more going on than measurement and study design issues, and heterogeneity of treatment effects might be expected depending on the social context. Tarkiainen et al speculate that their mixed finding might be explained by differences in where can i buy kamagra oral jelly family solidarity (a cultural characteristic) between the countries, viz. Italy is characterised by strong family responsibility for older people while contact with elderly parents may be looser in the Nordic countries (Indeed, the frequency of intergenerational contact has been put forward as one of the reasons why Italy suffered one of the worst erectile dysfunction treatment outbreaks in Europe.2). Future studies might attempt to incorporate these measures of social context into analysis to better understand the mechanisms at play.Improving exposure assessmentExposure assessment is at the crux of research on environmental drivers of health. Accurate exposure assessment that reflects personal exposure during a relevant time window allows for where can i buy kamagra oral jelly more precise estimation of the relationship between an environmental factor and healthy ageing.

Conversely, non-differential measurement error is likely to bias results towards the null.3 Therefore, if the exposures estimated across the studies in this special issue contain non-differential error, it is possible that this error accounts for the majority of null findings.While evidence is growing that environmental factors may drive mental health and well-being as we age, limitations in exposure assessment are the largest barriers to advancing the field. Poorly measured exposure data do not allow us to determine aetiologically relevant exposures in a way that is actionable by individuals or communities. Coarse exposure assessment limits statements about causal inference and provides little information on potential interventions for policymakers.4 5This where can i buy kamagra oral jelly lack of consistency in defining exposures could be at play in the study by Tarkiainen et al, where the authors observed inconsistent associations for antidepressant use by levels of urbanicity, land use mix, and population density across areas of Sweden, Finland and Italy. The definition of dense urban structure may differ greatly in Sweden and Finland compared with Italy. Are dense neighbourhoods monolithic apartment complexes or mixed-use vibrant where can i buy kamagra oral jelly communities?.

While both scenarios would constitute high density, the lack of a well-defined exposure makes it difficult to discern what the true exposure is that might drive antidepressant use. In addition, urbanicity is defined as ‘proportion of continuous urban fabric’. How would one design a randomised trial to experimentally expose someone to where can i buy kamagra oral jelly ‘urbanicity’?. And, assuming urbanicity does cause antidepressant use, how would researchers advise policymakers on how to change urbanicity?. Do where can i buy kamagra oral jelly we remove pavement?.

Knock down buildings?. Plant trees?. Broadly defined where can i buy kamagra oral jelly exposures create confusion in understanding exactly what causal question we are asking.Similarly, other studies used non-specific measures of the built environment in analyses, including Ruiz et al, Sund et al and Noordzij et al. Noordzij et al define exposure to green space based on the distance between a participant’s residential address and the nearest green space using data from the Urban Atlas dataset, which contains comparable land use and land cover data across Europe. The use of a harmonised green space metric allows for pooling of the data across all four cohorts.

However, the downside is that we have where can i buy kamagra oral jelly no information on the specific type of green space involved. Are grassy meadows comparable with wooded forests?. Are urban parks comparable with suburban where can i buy kamagra oral jelly parks?. The combination of these dissimilar green spaces, where some may positively influence depressive symptoms and others might not, contributes to exposure misclassification. The authors in Sund et al mention that urban areas provide an urban penalty by increasing exposure to air pollution, noise or violence, or conversely, may provide an urban advantage by providing higher access to cultural activities or social networks.

Future MINDMAP studies should measure and estimate the effects of these specific factors on health.Timmermans et al conducted an analysis on land use and loneliness in older adults from a cross-sectional analysis of two where can i buy kamagra oral jelly Dutch cohorts. In the time of erectile dysfunction treatment and increased social distancing, understanding environmental drivers of loneliness is all the more important. The authors find some suggestion that participants living in areas with higher land use mix had lower levels of loneliness, although this finding was not statistically significant. The authors proffer that land use mix could reflect ‘the availability where can i buy kamagra oral jelly of various destinations and neighbourhood resources in the local living environment’. However, land use mix could also be correlated with other factors, such as access to transit, access to green spaces or even something as simple as street benches, which encourage social interaction.

Future research could engage multiexposure models to isolate which specific where can i buy kamagra oral jelly factor appears to have the greatest impact on loneliness.Li et al evaluated whether a noise mitigation policy in Amsterdam led to an improvement in mental health. There are theoretical and empirical reasons why noise can affect residents’ mental health (not the least through sleep disruption). From an exposure assessment perspective, one of the things that researchers seldom bother to assess is how do the residents perceive noise. When people appraise the noise as unpredictable, beyond their control and not to where can i buy kamagra oral jelly their benefit, the mental health impacts are much worse. If, however, there are more positive appraisals (eg, residents have been told that the noise will last for a specified duration of time and is associated with some community benefit—for example, the construction of an attractive neighbourhood amenity—the mental health impacts will be less).

Self-reported data on noise perceptions, as well as control over noise, would be a worthwhile addition to the MINDMAP Project.Technological advances to address gapsRecent technological advances have provided researchers with tools that can fill many research gaps outlined above. We have where can i buy kamagra oral jelly new tools to estimate high-resolution metrics of mobility, human behaviour and psychological processes that occur within a day. Fernandes et al describe the development of a study that incorporates multiple tools for innovative perspectives on these factors. Their research protocol combines global positioning systems and accelerometer data, proximity detection to assess whether household members are close to each other for objective measures of social interactions, ecological where can i buy kamagra oral jelly momentary assessment prompts up to eight times per day to track momentary mood and stress and environmental perceptions, and electrodermal activity for the potential objective prediction of stress. These technologies provide moment-to-moment data on how environmental factors influence mood and stress, as well as how these relationships are impacted by social interaction, to provide a thorough understanding of the dynamic processes through which environmental exposures may drive mood changes.

Important studies such as this will unveil exciting perspectives on the fine-scale mechanisms at play and will fill gaps in the literature, which has previously focused on infrequent measurement of mental health outcomes (eg, every 2 years) or residence-based exposure assessment.In addition to these high-resolution measures of mobility and psychological processes, we now have access to spatial dataset that provides information on the environment in ways never before seen. Ubiquitous georeferenced street-level imagery, such as Google where can i buy kamagra oral jelly Street View, provides detailed, time-varying information on specific small-scale environmental factors.6 7 Recent advances in deep learning have made it possible for researchers to rigorously and systematically evaluate these images for exposure assessment at scale.8 We can now tease out exactly what is in each image, such as sidewalk availability or tree species, and link these images to the locations that they were gathered. These images have also been gathered for over a decade, so that we can evaluate how environments change over time. As mentioned above, measuring specific, time-varying environmental features has been challenging, and has hindered the ability of previous studies to isolate key health-promoting features of the environment. Applying deep learning to street-level images empowers the measurement of environmental factors in a high-resolution, where can i buy kamagra oral jelly specific, consistent and scalable manner across large areas.

Linking these measures to health will reveal policy-relevant and actionable information on how to optimise environments for mental health and well-beingModelling policy impactsUltimately, the goal of research on the environmental drivers of healthy ageing is to identify potential interventions and estimate how these interventions influence health outcomes. To this end, Yang et al employed an agent-based where can i buy kamagra oral jelly model to evaluate the impact of a free bus policy on both public transit use, as well as depression among older adults. They benchmarked this model against empirical data from England and ran several simulations to examine different policy scenarios. The authors’ model predicted that free bus policies lead to increased bus usage and decreased depression. In addition, improving attitudes towards the bus could where can i buy kamagra oral jelly enhance the effects of a free bus policy, particularly for those living close to public transit, as well as in scenarios where poorer populations live close to the city centre.

Although these agent-based models contain substantial assumptions, they provide crucial information to decision makers to enact policies that maximise health. Agent-based models also highlight the factors that may modulate the effectiveness of environmental interventions, which may indicate the need for multiscale interventions for optimal outcomes.Commentary on the MINDMAP ProjectWith all of the effort that went into harmonising exposure, outcomes and other core measures across six cohorts spanning seven countries (Wey et al), the findings gathered in this special issue provide novel cross-national findings. The MINDMAP collaboration has laid a groundwork for future research to harmonise where can i buy kamagra oral jelly environmental exposure data and health outcome information in multiple large studies across countries in Europe. The initial offering from the MINDMAP Project is only the beginning. Perhaps the best is yet to come..

Kamagra jelly price in canada

A broadly neutralising antibody to prevent HIV transmissionTwo HIV kamagra jelly price in canada prevention https://www.innovationsregion-mitteldeutschland.com/how-much-does-renova-cost-per-tube/ trials (HVTN 704/HPTN 085. HVTN 703/HPTN 081) enrolled 2699 at-risk cisgender men and transgender persons in the Americas and Europe and 1924 at-risk women in sub-Saharan Africa who were randomly assigned to receive the broadly neutralising antibody (bnAb) VRC01 or placebo (10 infusions at an interval of 8 weeks). Moderate-to-severe adverse events related to VRC01 kamagra jelly price in canada were uncommon. In a prespecified pooled analysis, over 20 months, VRC01 offered an estimated prevention efficacy of ~75% against VRC01-sensitive isolates (30% of kamagraes circulating in the trial regions).

However, VRC01 did not prevent with other HIV kamagra jelly price in canada isolates and overall HIV acquisition compared with placebo. The data provide proof of concept that bnAb can prevent HIV acquisition, although the approach is limited by viral diversity and potential selection of resistant isolates.Corey L, Gilbert PB, Juraska M, et al. Two randomized trials of neutralizing antibodies to prevent kamagra jelly price in canada HIV-1 acquisition. N Engl J Med.

2021;384:1003–1014.Seminal cytokine profiles are associated with the risk of HIV transmissionInvestigators analysed a panel of 34 cytokines/chemokines in blood and semen of men kamagra jelly price in canada (predominantly men who have sex with men) with HIV, comparing 21 who transmitted HIV to their partners and 22 who did not. Overall, 47% of men had a recent HIV , 19% were on antiretroviral therapy and 84% were viraemic. The cytokine profile in seminal fluid, but not in blood, differed significantly between transmitters and non-transmitters, with transmitters showing higher kamagra jelly price in canada seminal concentrations of interleukin 13 (IL-13), IL-15 and IL-33, and lower concentrations of interferon‐gamma, IL-15, macrophage colony-stimulating factor (M-CSF), IL-17, granulocyte-macrophage CSF (GM-CSF), IL-4, IL-16 and eotaxin. Although limited, the findings suggest that the seminal milieu modulates the risk of HIV transmission, providing a potential development opportunity for HIV prevention strategies.Vanpouille C, Frick A, Rawlings SA, et al.

Cytokine network and kamagra jelly price in canada sexual HIV transmission in men who have sex with men. Clin Infect Dis. 2020;71:2655–2662.The challenge of estimating global treatment eligibility for chronic hepatitis B from kamagra jelly price in canada incomplete datasetsWorldwide, over 250 million people are estimated to live with chronic hepatitis B (CHB), although only ~11% is diagnosed and a minority receives antiviral therapy. An estimate of the global proportion eligible for treatment was not previously available.

A systematic review analysed studies of CHB populations done kamagra jelly price in canada between 2007 and 2018 to estimate the prevalence of cirrhosis, abnormal alanine aminotransferase, hepatitis B kamagra DNA >2000 or >20 000 IU/mL, hepatitis B e-antigen, and overall eligibility for treatment as per WHO and other guidelines. The pooled treatment eligibility estimate was 19% (95% CI 18% to 20%), with about 10% requiring urgent treatment due to cirrhosis. However, the kamagra jelly price in canada estimate should be interpreted with caution due to incomplete data acquisition and reporting in available studies. Standardised reporting is needed to improve global and regional estimates of CHB treatment eligibility and guide effective policy formulation.Tan M, Bhadoria AS, Cui F, et al.

Estimating the proportion of people with chronic hepatitis B kamagra eligible kamagra jelly price in canada for hepatitis B antiviral treatment worldwide. A systematic review and meta-analysis. Lancet Gastroenterol Hepatol, kamagra jelly price in canada 2021. 6:106–119.Broad geographical disparity in the contribution of HIV to the burden of cervical cancerThis systematic review and meta-analysis estimated the contribution of HIV to the global and regional burden of cervical cancer using data from 24 studies which included 236 127 women with HIV.

HIV kamagra jelly price in canada markedly increased the risk of cervical cancer (pooled relative risk 6.07. 95% CI 4.40 to 8.37). In 2018, 4.9% (95% CI 3.6% to 6.4%) of cervical cancers were attributable to HIV globally, although the population-attributable fraction for HIV varied kamagra jelly price in canada geographically, reaching 21% (95% CI 15.6% to 26.8%) in the African region. Cervical cancer is preventable and treatable.

Efforts are needed to kamagra jelly price in canada expand access to HPV vaccination in sub-Saharan Africa. More immediately, there is an urgent need to integrate cervical cancer screening within HIV services.Stelzle D, Tanaka LF, Lee KK, et al. Estimates of the global burden of kamagra jelly price in canada cervical cancer associated with HIV. Lancet Glob Health.

2020. 9:e161–69.The complex relationship between serum vitamin D and persistence of high-risk human papilloma kamagra Most cervical high-risk human papilloma kamagra (hrHPV) s are transient and those that persist are more likely to progress to cancer. Based on the proposed immunomodulatory properties of vitamin D, a longitudinal study examined the association between serum concentrations of five vitamin D biomarkers and short-term persistent (vs transient or sporadic) detection of hrHPV in 72 women who collected monthly cervicovaginal swabs over 6 months. No significant associations were detected in the primary analysis.

In sensitivity analyses, after multiple adjustments, serum concentrations of multiple vitamin D biomarkers were positively associated with the short-term persistence of 14 selected hrHPV types. The relationship between vitamin D and hrHPV warrants closer examination. Studies should have longer follow-up, include populations with more diverse vitamin D concentrations and account for vitamin D supplementation.Troja C, Hoofnagle AN, Szpiro A, et al. Understanding the role of emerging vitamin D biomarkers on short-term persistence of high-risk HPV among mid-adult women.

J Infect Dis 2020. Online ahead of printPublished in STI—the editor’s choice. One in five cases of with Neisseria gonorrhoeae clear spontaneouslyStudies have indicated that Neisseria gonorrhoeae (NG) s can resolve spontaneously without antibiotic therapy. A substudy of a randomised trial investigated 405 untreated subjects (71% men) who underwent both pretrial and enrolment NG testing at the same anatomical site (genital, pharyngeal and rectal).

Based on nuclear acid amplification tests, 83 subjects (20.5%) showed clearance of the anatomical site within a median of 10 days (IQR 7–15) between tests. Those with spontaneous clearance were less likely to have concurrent chlamydia (p=0.029) and dysuria (p=0.035), but there were no differences in age, gender, sexual orientation, HIV status, number of previous NG episodes, and symptoms other than dysuria between those with and without clearance. Given the high rate of spontaneous resolution, point-of-care NG testing should be considered to reduce unnecessary antibiotic treatment.Mensforth S, Ayinde OC, Ross J. Spontaneous clearance of genital and extragenital Neisseria gonorrhoeae.

Data from GToG. STI 2020. 96:556–561.BackgroundReproductive aged women are at risk of both pregnancy and sexually transmitted s (STI). The modern contraceptive prevalence among married and unmarried women in South Africa is 54% and 64%, respectively, with injectable progestins being most widely used.1 Moreover, current global efforts aim towards all women having access to a range of reliable contraceptives options.2 The prevalences of chlamydia and gonorrhoea are high among women in Africa, particularly among younger women.

A recent meta-analysis of over 37 000 women estimated prevalences for chlamydia and gonorrhoea by region and population type (South Africa clinic/community-based, Eastern Africa higher-risk and Southern/Eastern Africa clinic community-based). High chlamydia and gonorrhoea prevalences were found among 15–24 year-old South African women and high risk populations in East Africa.3 Both chlamydia and gonorrhoea are associated with numerous comorbidities including pelvic inflammatory disease (PID), ectopic pregnancy, infertility, increased risk of HIV and other STIs, as well as significant social harm.4While STIs are a significant global health burden, data on STI prevalence by gender and drivers of are limited, hindering an effective public health response.5 Moreover, data on the association between contraceptive use and risk of non-HIV STIs are limited. The WHO recently reported stagnation in efforts to decrease global STI incidence.5 Understanding drivers of STI acquisition, including any possible associations with widely used contraceptive methods, is necessary to effectively target public health responses that reduce STI incidence and associated comorbidities.The ECHO Trial (ClinicalTrials.gov Identifier. NCT02550067) was a multicentre, open-label randomised trial of 7829 HIV-seronegative women seeking effective contraception in Eswatini, Kenya, South Africa and Zambia.

Detailed trial methods and results have been published.6 7 We conducted a secondary analysis of ECHO trial data to evaluate absolute and relative chlamydia and gonorrhoea final visit prevalences among women randomised to intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUD) and a levonorgestrel (LNG) implant.MethodsStudy design, participants and ethicsWomen were enrolled in the ECHO trial from December 2015 through September 2017. Institutional review boards at each site approved the study protocol and women provided written informed consent before any study procedures. In brief, women who were not pregnant, HIV-seronegative, aged 16–35 years, seeking effective contraception, without medical contraindications, willing to use the assigned method for 18 months, reported not using injectable, intrauterine or implantable contraception for the previous 6 months and reported being sexually active, were enrolled. At every visit, participants received HIV risk reduction counselling, HIV testing and STI management, condoms and, as it became a part of national standard of care, HIV pre-exposure prophylaxis.

Counselling messages related to HIV risk were implemented consistently across the three groups throughout the trial.6The trial was implemented in accordance with the Declaration of Helsinki and Good Clinical Practice. Informed consent was obtained from participants or their parents/guardians and human experimentation guidelines of the United States Department of Health and Human Services and those of the authors' institution(s) were followed.Contraceptive exposureAt enrolment, women were randomly assigned (1:1:1) to DMPA-IM, copper IUD or LNG implant.6 Participants received an injection of 150 mg/mL DMPA-IM (Depo Provera. Pfizer, Puurs, Belgium) at enrolment and every 3 months until the final visit at 18 months after enrolment, a copper IUD (Optima TCu380A. Injeflex, Sao Paolo, Brazil) or a LNG implant (Jadelle.

Bayer, Turku, Finland) at enrolment. Women returned for follow-up visits at 1 month after enrolment to address initial contraceptive side-effects and every 3 months thereafter, for up to 18 months with later enrolling participants contributing 12 to 18 months of follow-up. Visits included HIV serological testing, contraceptive counselling, syndromic STI management and safety monitoring.STI outcomesThe primary outcomes of this secondary analysis were prevalent chlamydia and gonorrhoea at the final visit. Syndromic STI management was provided at screening and all follow-up visits.

Nucleic acid amplification testing (NAAT) for Chlamydia trachomatis and Neisseria gonorrhoeae was conducted at screening and final visits, at the visit of HIV detection for participants who became HIV infected and at clinical discretion. Any untreated participants with positive NAAT results were contacted to return to the study clinic for treatment.CovariatesAt baseline (inclusive of screening and enrolment visits), we collected demographic, sexual and reproductive risk behaviour and reproductive and contraceptive history data. Baseline risk factors evaluated as covariates included age, whether the participant earned her own income, chlamydia and gonorrhoea status, herpes simplex kamagra type 2 (HSV-2) sero-status and suspected PID. Final visit factors evaluated as covariates included number of sex partners in the past 3 months, number of new sex partners in the past 3 months, HIV serostatus, HSV-2 serostatus, condom use in the past 3 months, sex exchanged for money/gifts, sex during vaginal bleeding, follow-up time and number of pelvic examinations during follow-up.

Age and HSV-2 serostatus were evaluated for effect measure modification.Statistical analysisWe conducted analyses using R V.3.5.3 (Vienna, Austria), and log-binomial regression to estimate chlamydia and gonorrhoea prevalences within each contraceptive group and pairwise prevalence ratios (PR) between each arm in as-randomised and consistent use analyses.In the as-randomised analysis, we analysed participants by the contraceptive method assigned at randomisation independent of method adherence. We estimated crude point prevalences by arm and study site and pairwise adjusted PRs.In the consistent use analysis, we only included women who initiated use of their randomised contraceptive method and maintained randomised method adherence throughout follow-up. We estimated crude point prevalences by arm and pairwise adjusted PRs, with evaluation of age and HSV-2 status first as potential effect measure modifiers, and all covariates above as potential confounders. Study site and age were retained in the final model.

Other covariates were retained if their inclusion in the base model led to a 10% change in the effect estimate through backwards selection.Supplementary analysesAdditional supporting analyses to assess postrandomisation potential sources of bias were conducted to inform interpretation of results. These include evaluation of recent sexual behaviour at enrolment, month 9 and the final visit. Cohort participation (ie, follow-up time, early discontinuation and timing of randomised method discontinuation) and health outcomes (ie, final visit HIV and HSV-2 status) and frequency and results of pelvic examinations by STI status, site and visit month by randomised arm.ResultsA total of 7829 women were randomly assigned as follows. 2609 to the DMPA-IM group, 2607 to the copper IUD group and 2613 to the LNG implant group (figure 1).

Participants were excluded if they were HIV positive at enrolment, did not have at least one HIV test or did not have chlamydia and gonorrhoea test results at the final visit. Overall, 90%, 94% and 93% from the DMPA-IM, copper IUD and LNG implant groups, respectively, were included in analyses.Study profile. DMPA-IM, depot medroxy progesterone acetate. IUD, intrauterine device.

LNG, levonorgestrel." data-icon-position data-hide-link-title="0">Figure 1 Study profile. DMPA-IM, depot medroxy progesterone acetate. IUD, intrauterine device. LNG, levonorgestrel.Participant characteristicsBaseline characteristics were similar across groups (table 1).

Nearly two-third of enrolled women (63%) were aged 24 and younger and 5768 (74%) of the study population resided in South Africa.View this table:Table 1 Participant baseline and final visit characteristicsThe duration of participation averaged 16 months with no differences between randomised groups (table 1). A total of 1468 (19%) women either did not receive their randomised method or discontinued use during follow-up. Overall method continuation rates were high with minimal differences between randomised groups when measured by person-years.6 The proportion, however, of method non-adherence as defined in this analysis (ie, did not receive randomised method at baseline or discontinued randomised method at any point during follow-up), was greater in the DMPA-IM group (26%), followed by the copper IUD (18%) and LNG implant (12%) groups. Timing of discontinuation also differed across methods.

During the first 6 months, method discontinuation was highest in the copper IUD group (7%) followed closely by DMPA-IM (6%) and LNG implant (4%) groups. Between 7 and 12 months of follow-up, it was highest in DMPA-IM group (15%), with equivalent proportions in the LNG implant (5%) and copper IUD (5%) groups.Point prevalences of chlamydia and gonorrhoea at baseline and final visitsIn total, 18% of women had chlamydia at baseline (figure 2A) and 15% at the final visit. Among women 24 years and younger, 22% and 20% had chlamydia at baseline and final visits, respectively. Women aged 25–35 at baseline were less likely to have chlamydia at both baseline (12%) and final visits (8%) compared with younger women.

Baseline chlamydia prevalence ranged from 5% in Zambia to 28% in the Western Cape, South Africa (figure 2B).Point prevalence (per 100 persons) of chlamydia and gonorrhoea at baseline and final visit by age category and study site region. Y-axis scale differs for chlamydia and gonorrhoea figures." data-icon-position data-hide-link-title="0">Figure 2 Point prevalence (per 100 persons) of chlamydia and gonorrhoea at baseline and final visit by age category and study site region. Y-axis scale differs for chlamydia and gonorrhoea figures.Among all women, 5% had gonorrhoea at baseline and the final visit (figure 2C). Women aged 24 and younger were more likely to have gonorrhoea compared with women aged 25 and older at both baseline (5% vs 4%, respectively) and the final visit (6% vs 3%, respectively).

Baseline gonorrhoea prevalence ranged from 3% in Zambia and Kenya to 9% in the Western Cape, South Africa (figure 2D). Similar prevalences were observed at the final visit.Point prevalences of chlamydia and gonorrhoea at final visit by randomised contraceptive methodFourteen per cent of women randomised to DMPA-IM, 15% to copper IUD and 17% to LNG implant had chlamydia at the final visit (table 2).View this table:Table 2 Chlamydia trachomatis and Neisseria gonorrhoeae prevalence at final visitThe prevalence of chlamydia did not significantly differ between DMPA-IM and copper IUD groups (PR 0.90, 95% CI (0.79 to 1.04)) or between copper IUD and LNG implant groups (PR 0.92, 95% CI (0.81 to 1.04)). Women in the DMPA-IM group, however, had a significantly lower risk of chlamydia compared with the LNG implant group (PR. 0.83, 95% CI (0.72 to 0.95)).

Findings from the consistent use analysis were similar, and neither age nor HSV-2 status modified the observed associations.Four per cent of women randomised to DMPA-IM, 6% to copper IUD and 5% to LNG implant had gonorrhoea at the final visit (table 2). Gonorrhoea prevalence did not significantly differ between DMPA-IM and LNG implant groups (PR. 0.79, 95% CI (0.61 to 1.03)) or between copper IUD and LNG implant groups (PR. 1.18, 95% CI (0.93 to 1.49)).

Women in the DMPA-IM group had a significantly lower risk of gonorrhoea compared with women in the copper IUD group (PR. 0.67, 95% CI (0.52 to 0.87)). Results from as randomised and continuous use analyses did not differ. And again, neither age nor HSV-2 status modified the observed associations.Clinical assessment by randomised contraceptive methodTo assess the potential for outcome ascertainment bias, we evaluated the frequency of pelvic examinations and abdominal/pelvic pain and discharge by study arm.

Women in the copper IUD group were generally more likely to receive a pelvic examination during follow-up as compared with women in the DMPA-IM and LNG implant groups (online supplemental appendix 1). Similarly, abdominal/pelvic pain on examination or abnormal discharge was observed most frequently in the copper IUD group. The number of pelvic examinations met the prespecified criteria for retention in the adjusted gonorrhoea model but not in the chlamydia model.Supplemental materialFrequency of syndromic symptoms and potential reAmong women who had chlamydia at baseline, 23% were also positive at the final visit (online supplemental appendix 2, figure 3A). Nine per cent of gonorrhoea-positive women at baseline were also positive at the final visit (online supplemental appendix 2, figure 3B).

Across both baseline and final visits, a minority of women with chlamydia or gonorrhoea presented with signs and/or symptoms. Among chlamydia-positive women, only 12% presented with either abnormal vaginal discharge and/or abdominal/pelvic pain at their test-positive visit (online supplemental appendix 2, figure 3C). Similarly, only 15% of gonorrhoea-positive women presented with abnormal vaginal discharge and/or abdominal/pelvic pain at their test-positive visit (online supplemental appendix 2, figure 3D).Potential re and symptoms among women with chlamydia or gonorrhoea. Data are pooled across the screening and final visits in figures (C) and (D).

Symptomatic is defined as presenting with abnormal vaginal discharge and/or abdominal/pelvic pain. Final visit is described as potential re because test of cure was not conducted following baseline diagnosis and treatment." data-icon-position data-hide-link-title="0">Figure 3 Potential re and symptoms among women with chlamydia or gonorrhoea. Data are pooled across the screening and final visits in figures (C) and (D). Symptomatic is defined as presenting with abnormal vaginal discharge and/or abdominal/pelvic pain.

Final visit is described as potential re because test of cure was not conducted following baseline diagnosis and treatment.DiscussionWe observed differences in final prevalences of chlamydia and gonorrhoea by contraceptive group in both as-randomised and consistent-use analyses. The DMPA-IM group had lower final visit chlamydia and gonorrhoea prevalences as compared with copper IUD and LNG implant groups, though only the DMPA-IM versus the copper IUD comparison of gonorrhoea and DMPA-IM versus LNG implant comparison of chlamydia reached statistical significance. These are novel findings that have not previously been reported to our knowledge and were determined in a randomised trial setting with high participant retention, robust biomarker testing and high randomised method adherence. Interestingly, the copper IUD group had higher gonorrhoea and lower chlamydia prevalence compared with the LNG implant group, though neither finding was statistically significant.Two recent systematic reviews of the association between contraceptives and STIs found inconsistent and insufficient evidence on the association between the contraceptive methods under study in ECHO and chlamydia and gonorrhoea.8 9 Neither systematic review identified any randomised studies or any direct comparative evidence for DMPA-IM, copper IUD and LNG implant, thus enabling a unique scientific contribution from this secondary trial analysis.

Nonetheless, these findings should be interpreted in light of biological plausibility, as well as the design strengths and limitations of this analysis.The emerging science on the biological mechanisms underlying HIV susceptibility demonstrates the complex relationship between the infectious pathogen, the host innate and adaptive immune response and the interaction of both with the vaginal microbiome and other -omes. Data on these factors in relationship to chlamydia and gonorrhoea acquisition are much more limited but can be assumed to be equally complex. Vaginal microbiome composition, including microbial metabolic by-products, have been shown to significantly modify risk of HIV acquisition and to vary with exogenous hormone exposure, menstrual cycle phase, ethnicity and geography.10–12 These same biological principles likely apply to chlamydia and gonorrhoea susceptibility. While DMPA-IM has been associated with decreased bacterial vaginosis (BV), initiation of the copper IUD has been associated with increased BV prevalence, and BV is associated with chlamydia and gonorrhoea acquisition.13 14 Moreover, Lactobacillus crispatus, which is less abundant in BV, has been shown to inhibit HeLa cell by Chlamydia trachomatis and inhibits growth of Neisseria gonorrhoeae in animal models.15 16 In addition, microbial community state types that are deficient in Lactobacillus crispatus and/or dominated by dysbiotic species are associated with inflammation, which is a driver of both STI and HIV susceptibility.

Thus, while the exact mechanisms of chlamydia and gonorrhoea in the presence of exogenous hormones and varying host microbiomes are unknown, it is biologically plausible that these complex factors may result in differential susceptibility to chlamydia and gonorrhoea among DMPA-IM, copper IUD and LNG implant users.An alternative explanation for these findings may be postrandomisation differences in clinical care and/or sexual behaviour. Participants in the copper IUD arm were more likely to have pelvic examinations and more likely to have discharge compared with women in the DMPA-IM and LNG implant groups. While interim STI testing and/or treatment were not documented, women in the copper IUD arm may have been more likely to receive syndromic STI treatment during follow-up due to more examination and observed discharge. More frequent STI treatment in the copper IUD group would theoretically lower the final visit point prevalence relative to women in the DMPA-IM and LNG implant arms, suggesting that the observed lower risk of STI in the DMPA-IM arm is not due to differential examination, testing and treatment.

Differential sexual risk behaviour may also have influenced the results. As reported previously, women in the DMPA-IM group less frequently reported condomless sex and multiple partners than women in the other groups, and both DMPA-IM and LNG implant users less frequently reported new partners and sex during menses than copper IUD users.6 Statistical control of self-reported sexual risk behaviour in the consistent-use analysis may have been inadequate if self-reported sexual behaviour was inaccurately or insufficiently reported.A second alternative explanation may be differences in randomised method non-adherence, which was greater in the DMPA-IM group, compared with copper IUD and LNG implant groups. Yet, the consistency of findings in the as-randomised and continuous use analyses suggests that method non-adherence had minimal effect on study outcomes. Taken as a whole, these findings indicate that there may be real differences in chlamydia and gonorrhoea risk associated with use of DMPA-IM, the copper IUD and LNG implant.

However, any true differential risk by method must be evaluated in light of the holistic benefits and risks of each method.The high observed chlamydia and gonorrhoea prevalences, despite intensive counselling and condom provision, warrants attention, particularly among women ages 24 years and younger and among women in South Africa and Eswatini. While the ECHO study was conducted in settings of high HIV/STI incidence, enrolment criteria did not purposefully target women at highest risk of HIV/STI in the trial communities, suggesting that the observed prevalences may be broadly applicable to women seeking effective contraception in those settings. Improved approaches are needed to prevent STIs, including options for expedited partner treatment, to prevent re.As expected, few women testing positive for chlamydia or gonorrhoea presented with symptoms (12% and 15%, respectively), and a substantial proportion of women who were positive and treated at baseline were infected at the final visit despite syndromic management during the follow-up. Given that syndromic management is the standard of care within primary health facilities in most trial settings, these data suggest that a large proportion of among reproductive aged women is missed, exacerbating the burden of curable STIs and associated morbidities.

Routine access to more reliable diagnostics, like NAAT and novel point-of-care diagnostic tests, will be key to managing asymptomatic STIs and reducing STI prevalence and related morbidities in these settings.17This secondary analysis of the ECHO trial has strengths and limitations. Strengths include the randomised design with comparator groups of equal STI baseline risk. Participants had high adherence to their randomised contraceptive method.6 While all participants received standardised clinical care and counselling, the unblinded randomisation may have allowed postrandomisation differences in STI risk over time by method. It is possible that participants modified their risk-taking behaviour based on study counselling messages regarding the potential association between DMPA-IM and HIV.In conclusion, our analyses suggest that DMPA-IM users may have lower risk of chlamydia and gonorrhoea compared with LNG implant and copper IUD users, respectively.

Further investigation is warranted to better understand the mechanisms of chlamydia and gonorrhoea susceptibility in the context of contraceptive use. Moreover, the high chlamydia and gonorrhoea prevalences in this population, independent of contraceptive method, warrants urgent attention.Key messagesThe prevalence of chlamydia and gonorrhoea varied by contraceptive method in this randomised trial.High chlamydia and gonorrhoea prevalences, despite intensive counselling and condom provision, warrants attention, particularly among young women in South Africa and Eswatini.Most chlamydia and gonorrhoea s were asymptomatic. Therefore, routine access to reliable diagnostics are needed to effectively manage and prevent STIs in African women..

A broadly where can i buy kamagra oral jelly neutralising antibody to prevent HIV transmissionTwo HIV prevention trials (HVTN 704/HPTN 085 How much does renova cost per tube. HVTN 703/HPTN 081) enrolled 2699 at-risk cisgender men and transgender persons in the Americas and Europe and 1924 at-risk women in sub-Saharan Africa who were randomly assigned to receive the broadly neutralising antibody (bnAb) VRC01 or placebo (10 infusions at an interval of 8 weeks). Moderate-to-severe adverse where can i buy kamagra oral jelly events related to VRC01 were uncommon. In a prespecified pooled analysis, over 20 months, VRC01 offered an estimated prevention efficacy of ~75% against VRC01-sensitive isolates (30% of kamagraes circulating in the trial regions).

However, VRC01 did not prevent with other HIV isolates and where can i buy kamagra oral jelly overall HIV acquisition compared with placebo. The data provide proof of concept that bnAb can prevent HIV acquisition, although the approach is limited by viral diversity and potential selection of resistant isolates.Corey L, Gilbert PB, Juraska M, et al. Two randomized trials of neutralizing antibodies to prevent where can i buy kamagra oral jelly HIV-1 acquisition. N Engl J Med.

2021;384:1003–1014.Seminal cytokine profiles are associated with the risk of HIV transmissionInvestigators analysed a panel of 34 cytokines/chemokines in blood and semen of men (predominantly men who have sex with men) with HIV, where can i buy kamagra oral jelly comparing 21 who transmitted HIV to their partners and 22 who did not. Overall, 47% of men had a recent HIV , 19% were on antiretroviral therapy and 84% were viraemic. The cytokine where can i buy kamagra oral jelly profile in seminal fluid, but not in blood, differed significantly between transmitters and non-transmitters, with transmitters showing higher seminal concentrations of interleukin 13 (IL-13), IL-15 and IL-33, and lower concentrations of interferon‐gamma, IL-15, macrophage colony-stimulating factor (M-CSF), IL-17, granulocyte-macrophage CSF (GM-CSF), IL-4, IL-16 and eotaxin. Although limited, the findings suggest that the seminal milieu modulates the risk of HIV transmission, providing a potential development opportunity for HIV prevention strategies.Vanpouille C, Frick A, Rawlings SA, et al.

Cytokine network and sexual HIV transmission where can i buy kamagra oral jelly in men who have sex with men. Clin Infect Dis. 2020;71:2655–2662.The challenge of estimating global treatment eligibility for chronic hepatitis B from incomplete datasetsWorldwide, over 250 million people are estimated to live with chronic hepatitis B (CHB), although only ~11% is diagnosed and a where can i buy kamagra oral jelly minority receives antiviral therapy. An estimate of the global proportion eligible for treatment was not previously available.

A systematic review analysed studies of CHB populations done between 2007 and 2018 to estimate the prevalence of cirrhosis, abnormal alanine aminotransferase, hepatitis B kamagra DNA >2000 or >20 000 IU/mL, hepatitis B where can i buy kamagra oral jelly e-antigen, and overall eligibility for treatment as per WHO and other guidelines. The pooled treatment eligibility estimate was 19% (95% CI 18% to 20%), with about 10% requiring urgent treatment due to cirrhosis. However, the estimate should be interpreted with caution due to incomplete data acquisition and reporting in available studies where can i buy kamagra oral jelly. Standardised reporting is needed to improve global and regional estimates of CHB treatment eligibility and guide effective policy formulation.Tan M, Bhadoria AS, Cui F, et al.

Estimating the where can i buy kamagra oral jelly proportion of people with chronic hepatitis B kamagra eligible for hepatitis B antiviral treatment worldwide. A systematic review and meta-analysis. Lancet Gastroenterol where can i buy kamagra oral jelly Hepatol, 2021. 6:106–119.Broad geographical disparity in the contribution of HIV to the burden of cervical cancerThis systematic review and meta-analysis estimated the contribution of HIV to the global and regional burden of cervical cancer using data from 24 studies which included 236 127 women with HIV.

HIV markedly increased the risk of cervical cancer (pooled relative risk 6.07 where can i buy kamagra oral jelly. 95% CI 4.40 to 8.37). In 2018, 4.9% (95% CI 3.6% to 6.4%) of cervical cancers were attributable to HIV globally, where can i buy kamagra oral jelly although the population-attributable fraction for HIV varied geographically, reaching 21% (95% CI 15.6% to 26.8%) in the African region. Cervical cancer is preventable and treatable.

Efforts are needed where can i buy kamagra oral jelly to expand access to HPV vaccination in sub-Saharan Africa. More immediately, there is an urgent need to integrate cervical cancer screening within HIV services.Stelzle D, Tanaka LF, Lee KK, et al. Estimates of the global burden of cervical cancer associated with HIV where can i buy kamagra oral jelly. Lancet Glob Health.

2020. 9:e161–69.The complex relationship between serum vitamin D and persistence of high-risk human papilloma kamagra Most cervical high-risk human papilloma kamagra (hrHPV) s are transient and those that persist are more likely to progress to cancer. Based on the proposed immunomodulatory properties of vitamin D, a longitudinal study examined the association between serum concentrations of five vitamin D biomarkers and short-term persistent (vs transient or sporadic) detection of hrHPV in 72 women who collected monthly cervicovaginal swabs over 6 months. No significant associations were detected in the primary analysis.

In sensitivity analyses, after multiple adjustments, serum concentrations of multiple vitamin D biomarkers were positively associated with the short-term persistence of 14 selected hrHPV types. The relationship between vitamin D and hrHPV warrants closer examination. Studies should have longer follow-up, include populations with more diverse vitamin D concentrations and account for vitamin D supplementation.Troja C, Hoofnagle AN, Szpiro A, et al. Understanding the role of emerging vitamin D biomarkers on short-term persistence of high-risk HPV among mid-adult women.

J Infect Dis 2020. Online ahead of printPublished in STI—the editor’s choice. One in five cases of with Neisseria gonorrhoeae clear spontaneouslyStudies have indicated that Neisseria gonorrhoeae (NG) s can resolve spontaneously without antibiotic therapy. A substudy of a randomised trial investigated 405 untreated subjects (71% men) who underwent both pretrial and enrolment NG testing at the same anatomical site (genital, pharyngeal and rectal).

Based on nuclear acid amplification tests, 83 subjects (20.5%) showed clearance of the anatomical site within a median of 10 days (IQR 7–15) between tests. Those with spontaneous clearance were less likely to have concurrent chlamydia (p=0.029) and dysuria (p=0.035), but there were no differences in age, gender, sexual orientation, HIV status, number of previous NG episodes, and symptoms other than dysuria between those with and without clearance. Given the high rate of spontaneous resolution, point-of-care NG testing should be considered to reduce unnecessary antibiotic treatment.Mensforth S, Ayinde OC, Ross J. Spontaneous clearance of genital and extragenital Neisseria gonorrhoeae.

Data from GToG. STI 2020. 96:556–561.BackgroundReproductive aged women are at risk of both pregnancy and sexually transmitted s (STI). The modern contraceptive prevalence among married and unmarried women in South Africa is 54% and 64%, respectively, with injectable progestins being most widely used.1 Moreover, current global efforts aim towards all women having access to a range of reliable contraceptives options.2 The prevalences of chlamydia and gonorrhoea are high among women in Africa, particularly among younger women.

A recent meta-analysis of over 37 000 women estimated prevalences for chlamydia and gonorrhoea by region and population type (South Africa clinic/community-based, Eastern Africa higher-risk and Southern/Eastern Africa clinic community-based). High chlamydia and gonorrhoea prevalences were found among 15–24 year-old South African women and high risk populations in East Africa.3 Both chlamydia and gonorrhoea are associated with numerous comorbidities including pelvic inflammatory disease (PID), ectopic pregnancy, infertility, increased risk of HIV and other STIs, as well as significant social harm.4While STIs are a significant global health burden, data on STI prevalence by gender and drivers of are limited, hindering an effective public health response.5 Moreover, data on the association between contraceptive use and risk of non-HIV STIs are limited. The WHO recently reported stagnation in efforts to decrease global STI incidence.5 Understanding drivers of STI acquisition, including any possible associations with widely used contraceptive methods, is necessary to effectively target public health responses that reduce STI incidence and associated comorbidities.The ECHO Trial (ClinicalTrials.gov Identifier. NCT02550067) was a multicentre, open-label randomised trial of 7829 HIV-seronegative women seeking effective contraception in Eswatini, Kenya, South Africa and Zambia.

Detailed trial methods and results have been published.6 7 We conducted a secondary analysis of ECHO trial data to evaluate absolute and relative chlamydia and gonorrhoea final visit prevalences among women randomised to intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUD) and a levonorgestrel (LNG) implant.MethodsStudy design, participants and ethicsWomen were enrolled in the ECHO trial from December 2015 through September 2017. Institutional review boards at each site approved the study protocol and women provided written informed consent before any study procedures. In brief, women who were not pregnant, HIV-seronegative, aged 16–35 years, seeking effective contraception, without medical contraindications, willing to use the assigned method for 18 months, reported not using injectable, intrauterine or implantable contraception for the previous 6 months and reported being sexually active, were enrolled. At every visit, participants received HIV risk reduction counselling, HIV testing and STI management, condoms and, as it became a part of national standard of care, HIV pre-exposure prophylaxis.

Counselling messages related to HIV risk were implemented consistently across the three groups throughout the trial.6The trial was implemented in accordance with the Declaration of Helsinki and Good Clinical Practice. Informed consent was obtained from participants or their parents/guardians and human experimentation guidelines of the United States Department of Health and Human Services and those of the authors' institution(s) were followed.Contraceptive exposureAt enrolment, women were randomly assigned (1:1:1) to DMPA-IM, copper IUD or LNG implant.6 Participants received an injection of 150 mg/mL DMPA-IM (Depo Provera. Pfizer, Puurs, Belgium) at enrolment and every 3 months until the final visit at 18 months after enrolment, a copper IUD (Optima TCu380A. Injeflex, Sao Paolo, Brazil) or a LNG implant (Jadelle.

Bayer, Turku, Finland) at enrolment. Women returned for follow-up visits at 1 month after enrolment to address initial contraceptive side-effects and every 3 months thereafter, for up to 18 months with later enrolling participants contributing 12 to 18 months of follow-up. Visits included HIV serological testing, contraceptive counselling, syndromic STI management and safety monitoring.STI outcomesThe primary outcomes of this secondary analysis were prevalent chlamydia and gonorrhoea at the final visit. Syndromic STI management was provided at screening and all follow-up visits.

Nucleic acid amplification testing (NAAT) for Chlamydia trachomatis and Neisseria gonorrhoeae was conducted at screening and final visits, at the visit of HIV detection for participants who became HIV infected and at clinical discretion. Any untreated participants with positive NAAT results were contacted to return to the study clinic for treatment.CovariatesAt baseline (inclusive of screening and enrolment visits), we collected demographic, sexual and reproductive risk behaviour and reproductive and contraceptive history data. Baseline risk factors evaluated as covariates included age, whether the participant earned her own income, chlamydia and gonorrhoea status, herpes simplex kamagra type 2 (HSV-2) sero-status and suspected PID. Final visit factors evaluated as covariates included number of sex partners in the past 3 months, number of new sex partners in the past 3 months, HIV serostatus, HSV-2 serostatus, condom use in the past 3 months, sex exchanged for money/gifts, sex during vaginal bleeding, follow-up time and number of pelvic examinations during follow-up.

Age and HSV-2 serostatus were evaluated for effect measure modification.Statistical analysisWe conducted analyses using R V.3.5.3 (Vienna, Austria), and log-binomial regression to estimate chlamydia and gonorrhoea prevalences within each contraceptive group and pairwise prevalence ratios (PR) between each arm in as-randomised and consistent use analyses.In the as-randomised analysis, we analysed participants by the contraceptive method assigned at randomisation independent of method adherence. We estimated crude point prevalences by arm and study site and pairwise adjusted PRs.In the consistent use analysis, we only included women who initiated use of their randomised contraceptive method and maintained randomised method adherence throughout follow-up. We estimated crude point prevalences by arm and pairwise adjusted PRs, with evaluation of age and HSV-2 status first as potential effect measure modifiers, and all covariates above as potential confounders. Study site and age were retained in the final model.

Other covariates were retained if their inclusion in the base model led to a 10% change in the effect estimate through backwards selection.Supplementary analysesAdditional supporting analyses to assess postrandomisation potential sources of bias were conducted to inform interpretation of results. These include evaluation of recent sexual behaviour at enrolment, month 9 and the final visit. Cohort participation (ie, follow-up time, early discontinuation and timing of randomised method discontinuation) and health outcomes (ie, final visit HIV and HSV-2 status) and frequency and results of pelvic examinations by STI status, site and visit month by randomised arm.ResultsA total of 7829 women were randomly assigned as follows. 2609 to the DMPA-IM group, 2607 to the copper IUD group and 2613 to the LNG implant group (figure 1).

Participants were excluded if they were HIV positive at enrolment, did not have at least one HIV test or did not have chlamydia and gonorrhoea test results at the final visit. Overall, 90%, 94% and 93% from the DMPA-IM, copper IUD and LNG implant groups, respectively, were included in analyses.Study profile. DMPA-IM, depot medroxy progesterone acetate. IUD, intrauterine device.

LNG, levonorgestrel." data-icon-position data-hide-link-title="0">Figure 1 Study profile. DMPA-IM, depot medroxy progesterone acetate. IUD, intrauterine device. LNG, levonorgestrel.Participant characteristicsBaseline characteristics were similar across groups (table 1).

Nearly two-third of enrolled women (63%) were aged 24 and younger and 5768 (74%) of the study population resided in South Africa.View this table:Table 1 Participant baseline and final visit characteristicsThe duration of participation averaged 16 months with no differences between randomised groups (table 1). A total of 1468 (19%) women either did not receive their randomised method or discontinued use during follow-up. Overall method continuation rates were high with minimal differences between randomised groups when measured by person-years.6 The proportion, however, of method non-adherence as defined in this analysis (ie, did not receive randomised method at baseline or discontinued randomised method at any point during follow-up), was greater in the DMPA-IM group (26%), followed by the copper IUD (18%) and LNG implant (12%) groups. Timing of discontinuation also differed across methods.

During the first 6 months, method discontinuation was highest in the copper IUD group (7%) followed closely by DMPA-IM (6%) and LNG implant (4%) groups. Between 7 and 12 months of follow-up, it was highest in DMPA-IM group (15%), with equivalent proportions in the LNG implant (5%) and copper IUD (5%) groups.Point prevalences of chlamydia and gonorrhoea at baseline and final visitsIn total, 18% of women had chlamydia at baseline (figure 2A) and 15% at the final visit. Among women 24 years and younger, 22% and 20% had chlamydia at baseline and final visits, respectively. Women aged 25–35 at baseline were less likely to have chlamydia at both baseline (12%) and final visits (8%) compared with younger women.

Baseline chlamydia prevalence ranged from 5% in Zambia to 28% in the Western Cape, South Africa (figure 2B).Point prevalence (per 100 persons) of chlamydia and gonorrhoea at baseline and final visit by age category and study site region. Y-axis scale differs for chlamydia and gonorrhoea figures." data-icon-position data-hide-link-title="0">Figure 2 Point prevalence (per 100 persons) of chlamydia and gonorrhoea at baseline and final visit by age category and study site region. Y-axis scale differs for chlamydia and gonorrhoea figures.Among all women, 5% had gonorrhoea at baseline and the final visit (figure 2C). Women aged 24 and younger were more likely to have gonorrhoea compared with women aged 25 and older at both baseline (5% vs 4%, respectively) and the final visit (6% vs 3%, respectively).

Baseline gonorrhoea prevalence ranged from 3% in Zambia and Kenya to 9% in the Western Cape, South Africa (figure 2D). Similar prevalences were observed at the final visit.Point prevalences of chlamydia and gonorrhoea at final visit by randomised contraceptive methodFourteen per cent of women randomised to DMPA-IM, 15% to copper IUD and 17% to LNG implant had chlamydia at the final visit (table 2).View this table:Table 2 Chlamydia trachomatis and Neisseria gonorrhoeae prevalence at final visitThe prevalence of chlamydia did not significantly differ between DMPA-IM and copper IUD groups (PR 0.90, 95% CI (0.79 to 1.04)) or between copper IUD and LNG implant groups (PR 0.92, 95% CI (0.81 to 1.04)). Women in the DMPA-IM group, however, had a significantly lower risk of chlamydia compared with the LNG implant group (PR. 0.83, 95% CI (0.72 to 0.95)).

Findings from the consistent use analysis were similar, and neither age nor HSV-2 status modified the observed associations.Four per cent of women randomised to DMPA-IM, 6% to copper IUD and 5% to LNG implant had gonorrhoea at the final visit (table 2). Gonorrhoea prevalence did not significantly differ between DMPA-IM and LNG implant groups (PR. 0.79, 95% CI (0.61 to 1.03)) or between copper IUD and LNG implant groups (PR. 1.18, 95% CI (0.93 to 1.49)).

Women in the DMPA-IM group had a significantly lower risk of gonorrhoea compared with women in the copper IUD group (PR. 0.67, 95% CI (0.52 to 0.87)). Results from as randomised and continuous use analyses did not differ. And again, neither age nor HSV-2 status modified the observed associations.Clinical assessment by randomised contraceptive methodTo assess the potential for outcome ascertainment bias, we evaluated the frequency of pelvic examinations and abdominal/pelvic pain and discharge by study arm.

Women in the copper IUD group were generally more likely to receive a pelvic examination during follow-up as compared with women in the DMPA-IM and LNG implant groups (online supplemental appendix 1). Similarly, abdominal/pelvic pain on examination or abnormal discharge was observed most frequently in the copper IUD group. The number of pelvic examinations met the prespecified criteria for retention in the adjusted gonorrhoea model but not in the chlamydia model.Supplemental materialFrequency of syndromic symptoms and potential reAmong women who had chlamydia at baseline, 23% were also positive at the final visit (online supplemental appendix 2, figure 3A). Nine per cent of gonorrhoea-positive women at baseline were also positive at the final visit (online supplemental appendix 2, figure 3B).

Across both baseline and final visits, a minority of women with chlamydia or gonorrhoea presented with signs and/or symptoms. Among chlamydia-positive women, only 12% presented with either abnormal vaginal discharge and/or abdominal/pelvic pain at their test-positive visit (online supplemental appendix 2, figure 3C). Similarly, only 15% of gonorrhoea-positive women presented with abnormal vaginal discharge and/or abdominal/pelvic pain at their test-positive visit (online supplemental appendix 2, figure 3D).Potential re and symptoms among women with chlamydia or gonorrhoea. Data are pooled across the screening and final visits in figures (C) and (D).

Symptomatic is defined as presenting with abnormal vaginal discharge and/or abdominal/pelvic pain. Final visit is described as potential re because test of cure was not conducted following baseline diagnosis and treatment." data-icon-position data-hide-link-title="0">Figure 3 Potential re and symptoms among women with chlamydia or gonorrhoea. Data are pooled across the screening and final visits in figures (C) and (D). Symptomatic is defined as presenting with abnormal vaginal discharge and/or abdominal/pelvic pain.

Final visit is described as potential re because test of cure was not conducted following baseline diagnosis and treatment.DiscussionWe observed differences in final prevalences of chlamydia and gonorrhoea by contraceptive group in both as-randomised and consistent-use analyses. The DMPA-IM group had lower final visit chlamydia and gonorrhoea prevalences as compared with copper IUD and LNG implant groups, though only the DMPA-IM versus the copper IUD comparison of gonorrhoea and DMPA-IM versus LNG implant comparison of chlamydia reached statistical significance. These are novel findings that have not previously been reported to our knowledge and were determined in a randomised trial setting with high participant retention, robust biomarker testing and high randomised method adherence. Interestingly, the copper IUD group had higher gonorrhoea and lower chlamydia prevalence compared with the LNG implant group, though neither finding was statistically significant.Two recent systematic reviews of the association between contraceptives and STIs found inconsistent and insufficient evidence on the association between the contraceptive methods under study in ECHO and chlamydia and gonorrhoea.8 9 Neither systematic review identified any randomised studies or any direct comparative evidence for DMPA-IM, copper IUD and LNG implant, thus enabling a unique scientific contribution from this secondary trial analysis.

Nonetheless, these findings should be interpreted in light of biological plausibility, as well as the design strengths and limitations of this analysis.The emerging science on the biological mechanisms underlying HIV susceptibility demonstrates the complex relationship between the infectious pathogen, the host innate and adaptive immune response and the interaction of both with the vaginal microbiome and other -omes. Data on these factors in relationship to chlamydia and gonorrhoea acquisition are much more limited but can be assumed to be equally complex. Vaginal microbiome composition, including microbial metabolic by-products, have been shown to significantly modify risk of HIV acquisition and to vary with exogenous hormone exposure, menstrual cycle phase, ethnicity and geography.10–12 These same biological principles likely apply to chlamydia and gonorrhoea susceptibility. While DMPA-IM has been associated with decreased bacterial vaginosis (BV), initiation of the copper IUD has been associated with increased BV prevalence, and BV is associated with chlamydia and gonorrhoea acquisition.13 14 Moreover, Lactobacillus crispatus, which is less abundant in BV, has been shown to inhibit HeLa cell by Chlamydia trachomatis and inhibits growth of Neisseria gonorrhoeae in animal models.15 16 In addition, microbial community state types that are deficient in Lactobacillus crispatus and/or dominated by dysbiotic species are associated with inflammation, which is a driver of both STI and HIV susceptibility.

Thus, while the exact mechanisms of chlamydia and gonorrhoea in the presence of exogenous hormones and varying host microbiomes are unknown, it is biologically plausible that these complex factors may result in differential susceptibility to chlamydia and gonorrhoea among DMPA-IM, copper IUD and LNG implant users.An alternative explanation for these findings may be postrandomisation differences in clinical care and/or sexual behaviour. Participants in the copper IUD arm were more likely to have pelvic examinations and more likely to have discharge compared with women in the DMPA-IM and LNG implant groups. While interim STI testing and/or treatment were not documented, women in the copper IUD arm may have been more likely to receive syndromic STI treatment during follow-up due to more examination and observed discharge. More frequent STI treatment in the copper IUD group would theoretically lower the final visit point prevalence relative to women in the DMPA-IM and LNG implant arms, suggesting that the observed lower risk of STI in the DMPA-IM arm is not due to differential examination, testing and treatment.

Differential sexual risk behaviour may also have influenced the results. As reported previously, women in the DMPA-IM group less frequently reported condomless sex and multiple partners than women in the other groups, and both DMPA-IM and LNG implant users less frequently reported new partners and sex during menses than copper IUD users.6 Statistical control of self-reported sexual risk behaviour in the consistent-use analysis may have been inadequate if self-reported sexual behaviour was inaccurately or insufficiently reported.A second alternative explanation may be differences in randomised method non-adherence, which was greater in the DMPA-IM group, compared with copper IUD and LNG implant groups. Yet, the consistency of findings in the as-randomised and continuous use analyses suggests that method non-adherence had minimal effect on study outcomes. Taken as a whole, these findings indicate that there may be real differences in chlamydia and gonorrhoea risk associated with use of DMPA-IM, the copper IUD and LNG implant.

However, any true differential risk by method must be evaluated in light of the holistic benefits and risks of each method.The high observed chlamydia and gonorrhoea prevalences, despite intensive counselling and condom provision, warrants attention, particularly among women ages 24 years and younger and among women in South Africa and Eswatini. While the ECHO study was conducted in settings of high HIV/STI incidence, enrolment criteria did not purposefully target women at highest risk of HIV/STI in the trial communities, suggesting that the observed prevalences may be broadly applicable to women seeking effective contraception in those settings. Improved approaches are needed to prevent STIs, including options for expedited partner treatment, to prevent re.As expected, few women testing positive for chlamydia or gonorrhoea presented with symptoms (12% and 15%, respectively), and a substantial proportion of women who were positive and treated at baseline were infected at the final visit despite syndromic management during the follow-up. Given that syndromic management is the standard of care within primary health facilities in most trial settings, these data suggest that a large proportion of among reproductive aged women is missed, exacerbating the burden of curable STIs and associated morbidities.

Routine access to more reliable diagnostics, like NAAT and novel point-of-care diagnostic tests, will be key to managing asymptomatic STIs and reducing STI prevalence and related morbidities in these settings.17This secondary analysis of the ECHO trial has strengths and limitations. Strengths include the randomised design with comparator groups of equal STI baseline risk. Participants had high adherence to their randomised contraceptive method.6 While all participants received standardised clinical care and counselling, the unblinded randomisation may have allowed postrandomisation differences in STI risk over time by method. It is possible that participants modified their risk-taking behaviour based on study counselling messages regarding the potential association between DMPA-IM and HIV.In conclusion, our analyses suggest that DMPA-IM users may have lower risk of chlamydia and gonorrhoea compared with LNG implant and copper IUD users, respectively.

Further investigation is warranted to better understand the mechanisms of chlamydia and gonorrhoea susceptibility in the context of contraceptive use. Moreover, the high chlamydia and gonorrhoea prevalences in this population, independent of contraceptive method, warrants urgent attention.Key messagesThe prevalence of chlamydia and gonorrhoea varied by contraceptive method in this randomised trial.High chlamydia and gonorrhoea prevalences, despite intensive counselling and condom provision, warrants attention, particularly among young women in South Africa and Eswatini.Most chlamydia and gonorrhoea s were asymptomatic. Therefore, routine access to reliable diagnostics are needed to effectively manage and prevent STIs in African women..